<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">74295</article-id><article-id pub-id-type="doi">10.7554/eLife.74295</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Satellite glia modulate sympathetic neuron survival, activity, and autonomic function</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-257107"><name><surname>Mapps</surname><given-names>Aurelia A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7956-2465</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257108"><name><surname>Boehm</surname><given-names>Erica</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-206788"><name><surname>Beier</surname><given-names>Corinne</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0698-7219</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257109"><name><surname>Keenan</surname><given-names>William T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa1">†</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-190031"><name><surname>Langel</surname><given-names>Jennifer</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257110"><name><surname>Liu</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289093"><name><surname>Thomsen</surname><given-names>Michael B</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-127912"><name><surname>Hattar</surname><given-names>Samer</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3124-9525</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31939"><name><surname>Zhao</surname><given-names>Haiqing</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4275-9843</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257111"><name><surname>Tampakakis</surname><given-names>Emmanouil</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-18015"><name><surname>Kuruvilla</surname><given-names>Rejji</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2851-675X</contrib-id><email>rkuruvilla@jhu.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00za53h95</institution-id><institution>Department of Biology, Johns Hopkins University</institution></institution-wrap><addr-line><named-content content-type="city">Baltimore</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04xeg9z08</institution-id><institution>Section on Light and Circadian Rhythms (SLCR), National Institute of Mental Health</institution></institution-wrap><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00za53h95</institution-id><institution>Department of Medicine, Division of Cardiology, Johns Hopkins University</institution></institution-wrap><addr-line><named-content content-type="city">Baltimore</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Chao</surname><given-names>Moses V</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/005dvqh91</institution-id><institution>New York University Langone Medical Center</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Wong</surname><given-names>Ma-Li</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01q1z8k08</institution-id><institution>State University of New York Upstate Medical University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Department of Neuroscience, The Scripps Research Institute, California, United States</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>23</day><month>08</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e74295</elocation-id><history><date date-type="received" iso-8601-date="2021-09-28"><day>28</day><month>09</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-08-22"><day>22</day><month>08</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-09-23"><day>23</day><month>09</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.09.23.461591"/></event></pub-history><permissions><ali:free_to_read/><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><ali:license_ref>http://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0 public domain dedication</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-74295-v3.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-74295-figures-v3.pdf"/><abstract><p>Satellite glia are the major glial cells in sympathetic ganglia, enveloping neuronal cell bodies. Despite this intimate association, the extent to which sympathetic functions are influenced by satellite glia in vivo remains unclear. Here, we show that satellite glia are critical for metabolism, survival, and activity of sympathetic neurons and modulate autonomic behaviors in mice. Adult ablation of satellite glia results in impaired mTOR signaling, soma atrophy, reduced noradrenergic enzymes, and loss of sympathetic neurons. However, persisting neurons have elevated activity, and satellite glia-ablated mice show increased pupil dilation and heart rate, indicative of enhanced sympathetic tone. Satellite glia-specific deletion of Kir4.1, an inward-rectifying potassium channel, largely recapitulates the cellular defects observed in glia-ablated mice, suggesting that satellite glia act in part via K<sup>+</sup>-dependent mechanisms. These findings highlight neuron–satellite glia as functional units in regulating sympathetic output, with implications for disorders linked to sympathetic hyper-activity such as cardiovascular disease and hypertension.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>satellite glia</kwd><kwd>sympathetic neuron</kwd><kwd>activity</kwd><kwd>trophic support</kwd><kwd>metabolism</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NS073751</award-id><principal-award-recipient><name><surname>Kuruvilla</surname><given-names>Rejji</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NS107342</award-id><principal-award-recipient><name><surname>Kuruvilla</surname><given-names>Rejji</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>DGE-1746891</award-id><principal-award-recipient><name><surname>Mapps</surname><given-names>Aurelia A</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DC016065</award-id><principal-award-recipient><name><surname>Zhao</surname><given-names>Haiqing</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>EY027202</award-id><principal-award-recipient><name><surname>Zhao</surname><given-names>Haiqing</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>ZIAMH002964</award-id><principal-award-recipient><name><surname>Hattar</surname><given-names>Samer</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Satellite glia provide trophic support to adult sympathetic neurons and modulate neuronal activity and autonomic function in mice.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The sympathetic nervous system prepares the body for ‘fight or flight’ responses and maintains homeostasis during daily activities such as exercise, digestion, or regulation of body temperature. Post-ganglionic neurons, which reside in sympathetic ganglia and project axons to innervate diverse peripheral organs and tissues, mediate key autonomic effects, including cardiac output, metabolism, and immune function (<xref ref-type="bibr" rid="bib33">Goldstein, 2013</xref>). Satellite glia are the major glial cells in sympathetic ganglia (<xref ref-type="bibr" rid="bib35">Hanani, 2010</xref>; <xref ref-type="bibr" rid="bib57">Mapps et al., 2021</xref>) and have a unique architecture in completely enveloping neuronal cell bodies (<xref ref-type="bibr" rid="bib20">Elfvin and Forsman, 1978</xref>; <xref ref-type="bibr" rid="bib29">Gabella et al., 1988</xref>). Each neuron and associated glia are thought to form a discrete structural and functional unit (<xref ref-type="bibr" rid="bib35">Hanani, 2010</xref>). Despite this intimate association, the functions of satellite glial cells in the sympathetic nervous system, particularly in vivo, are vastly understudied.</p><p>Satellite glia have been largely characterized by their distinctive location and morphology in peripheral ganglia (<xref ref-type="bibr" rid="bib20">Elfvin and Forsman, 1978</xref>; <xref ref-type="bibr" rid="bib29">Gabella et al., 1988</xref>). Like neurons, satellite glial cells are derived from multipotent neural crest precursors and form thin cytoplasmic sheaths around cell bodies, dendrites, and synapses of sympathetic neurons, with only 20 nm of space, the width of a synaptic cleft, between neuronal and glial membranes (<xref ref-type="bibr" rid="bib20">Elfvin and Forsman, 1978</xref>; <xref ref-type="bibr" rid="bib29">Gabella et al., 1988</xref>; <xref ref-type="bibr" rid="bib35">Hanani, 2010</xref>; <xref ref-type="bibr" rid="bib70">Pannese, 1981</xref>). Multiple satellite glia surround a single neuron and are connected with each other, and with neurons, via gap junctions, with the number of glial cells per neuron being positively correlated to soma size (<xref ref-type="bibr" rid="bib20">Elfvin and Forsman, 1978</xref>; <xref ref-type="bibr" rid="bib35">Hanani, 2010</xref>; <xref ref-type="bibr" rid="bib53">Ledda et al., 2004</xref>). This unique arrangement places satellite glial cells in an ideal position to be critical regulators of neuronal connectivity, synaptic transmission, and homeostasis. Studies in sympathetic neuron–glia co-cultures have suggested roles for satellite glia in promoting dendrite growth, synapse formation, modulating extracellular ion and neurotransmitter concentrations, and regulating synaptic transmission (<xref ref-type="bibr" rid="bib21">Enes et al., 2020</xref>; <xref ref-type="bibr" rid="bib25">Feldman-Goriachnik et al., 2018</xref>; <xref ref-type="bibr" rid="bib35">Hanani, 2010</xref>; <xref ref-type="bibr" rid="bib81">Tropea et al., 1988</xref>). Satellite glia also envelop neuronal cell bodies in sensory ganglia in the peripheral nervous system (PNS) (<xref ref-type="bibr" rid="bib36">Hanani and Spray, 2020</xref>). Recent studies implicate sensory satellite glia in regulating chronic pain through modulating neuronal hyper-excitability (<xref ref-type="bibr" rid="bib45">Kim et al., 2016</xref>), and in promoting axon regeneration after peripheral nerve injury in vivo (<xref ref-type="bibr" rid="bib4">Avraham et al., 2020</xref>). Satellite glia have been proposed to be closest to astrocytes in the central nervous system (CNS) with respect to expression of machinery related to neurotransmitter uptake/turnover, inward-rectifying potassium channels, functional coupling via gap junctions, and close association with synapses (<xref ref-type="bibr" rid="bib36">Hanani and Spray, 2020</xref>; <xref ref-type="bibr" rid="bib37">Hanani and Verkhratsky, 2021</xref>). In contrast to the wealth of information on CNS astrocytes and emerging evidence of the significance of sensory satellite glia in the PNS, little is known about the functions of satellite glia in the sympathetic nervous system in vivo.</p><p>Here, using genetic ablation in mice, we reveal that loss of satellite glia results in impaired metabolic signaling, soma atrophy, reduced expression of noradrenergic enzymes, and enhanced apoptosis of adult sympathetic neurons. The persisting neurons, however, show elevated activity as revealed by increased neuronal c-Fos expression. Consistently, satellite glia-ablated mice had enhanced circulating norepinephrine (NE) and elevated heart rate, indicative of heightened sympathetic tone. We further deleted Kir4.1, an inward-rectifying potassium channel, specifically in satellite glia in mice. Satellite glia-specific deletion of Kir4.1 largely recapitulates the cellular phenotypes observed in glia-ablated mice, suggesting that satellite glia support neurons, in part, via K<sup>+</sup>-dependent mechanisms. These findings reveal that satellite glia provide critical metabolic and trophic support to sympathetic neurons and are modulators of the ganglionic milieu, neuronal activity, and resulting autonomic behaviors.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Inducible ablation of satellite glia using BLBP:iDTA mice</title><p><italic>Fabp7,</italic> which encodes for brain lipid binding protein (BLBP), a fatty acid transporter, is one of the most highly expressed transcripts in mouse satellite glial cells (<xref ref-type="bibr" rid="bib4">Avraham et al., 2020</xref>; <xref ref-type="bibr" rid="bib51">Kurtz et al., 1994</xref>; <xref ref-type="bibr" rid="bib58">Mapps et al., 2022</xref>). Using immunostaining for BLBP and tyrosine hydroxylase (TH), a marker for noradrenergic sympathetic neurons, we observed BLBP-positive satellite glia in the mouse sympathetic ganglia (superior cervical ganglia [SCG]) at both developmental and adult stages (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). BLBP labeling was ‘patchy’ in the embryonic and neonatal ganglia, a period when satellite glia undergo migration into the ganglia and are also proliferating (<xref ref-type="bibr" rid="bib34">Hall and Landis, 1992</xref>). However, by 2 weeks after birth, BLBP-positive satellite glial cells had expanded processes around neuronal cell bodies and formed thin ring-like glial sheaths around neuronal somas when observed at P31 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>DTA-mediated ablation of satellite glia in sympathetic ganglia.</title><p>(<bold>A</bold>) Satellite glial cells, immunolabeled with brain lipid binding protein (BLBP, green), progressively ensheathe sympathetic neuron cell bodies, labeled with tyrosine hydroxylase (TH, magenta) in the superior cervical ganglia (SCG) during development. Time points shown are embryonic day 16.5 (E16.5) and postnatal days P1, P14, and P31. Scale bar: 30 μm. (<bold>B</bold>) Reduced BLBP expression in BLBP:iDTA SCG relative to control ganglia at 14 days after the last tamoxifen injection (14 dpi). Scale bar: 100 μm. (<bold>C</bold>) Increased apoptosis in BLBP:iDTA SCG (outlined in red dashed line) compared to controls as detected by TUNEL labeling at 5 days post-tamoxifen injection (5 dpi). Scale bar: 100 μm. (<bold>D</bold>) Quantification of apoptotic cells in SCGs at 5 dpi from n = 4 control and 3 mutant mice. Data are means ± SEM. *p&lt;0.05, <italic>t</italic>-test. (<bold>E</bold>) Increased apoptosis of satellite glial cells assessed by Sox10 immunostaining (green) and TUNEL labeling (red) in BLBP:iDTA sympathetic ganglia compared to control at 5 dpi. DAPI channel is shown in gray. Arrowheads indicate TUNEL<sup>+</sup>;Sox10<sup>+</sup> cells. Scale bar: 30 µm. (<bold>F</bold>) Neuronal apoptosis is similar between BLBP:iDTA and control ganglia at 5 dpi as assessed by TrkA immunostaining (magenta) and TUNEL labeling (green). DAPI channel is shown in gray. Arrowheads indicate TUNEL<sup>+</sup>;TrkA<sup>+</sup> neurons. Scale bar: 30 µm. (<bold>G</bold>) Quantification of TUNEL<sup>+</sup>;Sox10<sup>+</sup> cells expressed as a % of Sox10<sup>+</sup> cells. Data are presented as means ± SEM from n = 6 control and 4 mutant mice, **p&lt;0.05, <italic>t</italic>-test. (<bold>H</bold>) Quantification of TUNEL<sup>+</sup>;TrkA<sup>+</sup> cells expressed as a % of TrkA<sup>+</sup> cells. Data are presented as means ± SEM from n = 4 mice per genotype, n.s, not significant, <italic>t</italic>-test. (<bold>I</bold>) Decreased association of Sox2-labeled satellite glia (green) with TH-positive sympathetic neurons (magenta) in BLBP:iDTA sympathetic ganglia compared to controls at 14 dpi. Arrows indicate Sox2-labeled nuclei of satellite glia associated with TH-positive sympathetic neuron cell bodies, while arrowheads indicate Sox2-labeled nuclei not abutting neuronal soma. Gain in both images has been set to the same level for a better visualization of Sox2-labeled nuclei in mutant ganglia. Scale bar: 30 μm. (<bold>J</bold>) Quantification of Sox2-positive cells in control and BLBP:iDTA SCGs at 14 dpi. Data are presented as mean ± SEM from n = 5 control and 6 mutant animals, **p&lt;0.01, <italic>t</italic>-test. (<bold>K</bold>) TH DAB immunohistochemistry and hematoxylin staining shows fewer satellite glia nuclei (blue) associated with TH-labeled sympathetic neuron cell bodies (brown) in BLBP:iDTA ganglia at 14 dpi. Scale bar: 30 µm. (<bold>L</bold>) Quantification of glial nuclei associated with neuronal soma. Data are presented as means ± SEM from n = 6 control and 3 mutant animals, **p&lt;0.05, <italic>t</italic>-test.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Raw data for neuronal and glia apoptosis and glia cell counts.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74295-fig1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74295-fig1-v3.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Brain lipid binding protein (BLBP) is a specific marker for adult satellite glial cells.</title><p>(<bold>A</bold>) <italic>Fabp7</italic> mRNA is enriched in satellite glial cells compared to other ganglionic cell types based on single-cell RNA-sequencing analysis of sympathetic (superior cervical ganglia) and sensory (dorsal root ganglia) from adult mice (postnatal days 30–45) (<xref ref-type="bibr" rid="bib58">Mapps et al., 2022</xref>). Expression is normalized to cell counts for individual ganglionic cell types. (<bold>B</bold>) Tamoxifen-induced-mEGFP reporter expression in sympathetic ganglia from <italic>Fabp7-CreER2;ROSA26<sup>mEGFP</sup></italic> mice. Scale bar: 100 μm for left panel and 30 μm for right panel. (<bold>C–F</bold>) Co-localization of m-EGFP signal with Kir4.1 immunoreactivity (for satellite glia), but not with tyrosine hydroxylase (TH; sympathetic neurons), IBA-1 (macrophages), or Pdgfrβ (vascular mural cells) in <italic>Fabp7-CreER2;ROSA26<sup>mEGFP</sup></italic> sympathetic ganglia. Arrowheads in (<bold>C</bold>) indicate co-localization of mEGFP and Kir4.1. Scale bar: 30 μm.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Raw data for normalized Fabp7 in sympathetic ganglia.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74295-fig1-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74295-fig1-figsupp1-v3.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Satellite glia ablation in BLBP:iDTA sympathetic ganglia.</title><p>(<bold>A</bold>) Sox2 (green) and tyrosine hydroxylase (TH; magenta) immunostaining in BLBP:iDTA and control sympathetic ganglia at 5 dpi. Arrows indicate Sox2-labeled nuclei associated with sympathetic neuron cell bodies, while arrowheads indicate Sox2-labeled nuclei that are not adjacent to neuronal soma. Scale bar: 30 μm. (<bold>B</bold>) Quantification shows similar numbers of Sox2-labeled satellite glial cells in control and mutant ganglia at 5 dpi. Data are means ± SEM from n = 4 animals per genotype, **p&lt;0.01, n.s., not significant, <italic>t</italic>-test. (<bold>C</bold>) Fewer Sox2-positive satellite glia are found adjacent to neuron cell bodies. Data are means ± SEM from n = 4 animals per genotype, **p&lt;0.01, <italic>t</italic>-test. (<bold>D, E</bold>) Binary images of Sox2-immunolabeled cells in BLBP:iDTA and control sympathetic ganglia at 14 dpi (<bold>D</bold>) and 5 dpi (<bold>E</bold>). Images were generated by filtering and thresholding using ImageJ. Scale bar: 30 μm. (<bold>F, G</bold>) Quantification of Sox2-labeled cells in binary images of mutant and control ganglia at 14 dpi (<bold>F</bold>) and 5 dpi (<bold>G</bold>). (<bold>F</bold>) Data are means ± SEM from n = 4 animals per genotype, **p&lt;0.01, <italic>t</italic>-test, (<bold>G</bold>) n.s., not significant, <italic>t</italic>-test. (<bold>H</bold>) Downregulated expression of satellite glia-enriched transcripts in BLBP:iDTA sympathetic ganglia at 14 dpi as assessed by qPCR analysis. Data are means ± SEM from n = 3–5 animals per genotype, *p&lt;0.05, **p&lt;0.01, <italic>t</italic>-test with Bonferroni–Dunn’s correction.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Raw data for glia cell counts and transcript changes in sympathetic ganglia.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74295-fig1-figsupp2-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74295-fig1-figsupp2-v3.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Satellite glia depletion does not induce macrophage infiltration or proliferative changes in sympathetic ganglia.</title><p>(<bold>A, B</bold>) Satellite glia depletion does not induce an increase in IBA-1-expressing macrophages in sympathetic ganglia. Scale bar: 30 µm. Data are means ± SEM from n = 5 animals per genotype, n.s., not significant, <italic>t</italic>-test. (<bold>C, D</bold>) Proliferation in superior cervical ganglia (SCG) (outlined by dashed line) was not altered by satellite glia depletion as assessed by EDU labeling. Scale bar: 100 µm. Data are means ± SEM from n = 5 animals per genotype, n.s., not significant, <italic>t</italic>-test.</p><p><supplementary-material id="fig1s3sdata1"><label>Figure 1—figure supplement 3—source data 1.</label><caption><title>Raw data for macrophage and cell proliferation analyses.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74295-fig1-figsupp3-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74295-fig1-figsupp3-v3.tif"/></fig></fig-group><p>In the adult PNS, BLBP expression is restricted to satellite glia and is not detected in Schwann cells based on single-cell RNA-sequencing analysis and characterization of <italic>Fabp7-CreER2-</italic>driven reporter mice (<xref ref-type="bibr" rid="bib4">Avraham et al., 2020</xref>). Using data sets from our recently published single-cell RNA-sequencing analysis of peripheral sympathetic and sensory ganglia from adult mice (postnatal days 30–45) (<xref ref-type="bibr" rid="bib58">Mapps et al., 2022</xref>), we found that BLBP (<italic>Fabp7</italic>) is ~140-fold enriched in satellite glial cells compared to other ganglionic cell types (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Of note, Schwann cells are scarce in adult sympathetic ganglia compared to sensory ganglia based on single-cell RNA-sequencing analyses (<xref ref-type="bibr" rid="bib58">Mapps et al., 2022</xref>). To further ensure the cellular specificity of BLBP, we generated genetic reporter mice by crossing <italic>Fabp7-CreER2</italic> mice with <italic>ROSA26<sup>mEGFP</sup></italic> mice (<xref ref-type="bibr" rid="bib65">Muzumdar et al., 2007</xref>), which drives expression of membrane-tagged EGFP (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). We found that tamoxifen treatment (180 mg/kg body weight for five consecutive days) in <italic>Fabp7-CreER2;ROSA26<sup>mEGFP</sup></italic> mice resulted in m-EGFP reporter expression in satellite glia marked by Kir4.1 immunolabeling (<xref ref-type="bibr" rid="bib84">Vit et al., 2006</xref>), but not in TH-positive sympathetic neurons, IBA1-labeled macrophages, or Pdgfrβ-labeled vascular mural cells in sympathetic ganglia (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C–F</xref>). Together, these results are consistent with previous studies (<xref ref-type="bibr" rid="bib6">Avraham et al., 2022</xref>; <xref ref-type="bibr" rid="bib4">Avraham et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Avraham et al., 2021</xref>; <xref ref-type="bibr" rid="bib58">Mapps et al., 2022</xref>) showing that BLBP is a specific marker for satellite glia in adult mice.</p><p>Next, to accomplish ablation of satellite glia, we crossed <italic>Fabp7-CreER2</italic> mice (<xref ref-type="bibr" rid="bib59">Maruoka et al., 2011</xref>) with <italic>ROSA26<sup>eGFP-DTA</sup></italic> mice (<xref ref-type="bibr" rid="bib41">Ivanova et al., 2005</xref>), where Cre drives expression of a copy of diphtheria toxin subunit A (DTA). At postnatal day 30, <italic>Fabp7-CreER2;ROSA26<sup>eGFP-DTA</sup></italic> mice were injected with either vehicle (corn oil) or tamoxifen (180 mg/kg body weight) for five consecutive days, and all analyses were performed at 5 or 14 days post injection. By 2 weeks, we observed a drastic loss of BLBP expression in sympathetic (superior cervical) ganglia from tamoxifen-treated mice (henceforth referred to as BLBP:iDTA mice) compared to vehicle-injected control (Ctrl) mice (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). While satellite glia in control ganglia formed characteristic ring-like structures around neuronal soma, glial organization was disrupted in mutant mice with diminished BLBP staining detected within the ganglia. To determine whether DTA expression results in cell death, we assessed apoptosis using TUNEL labeling and observed a threefold increase in TUNEL-positive cells in BLBP:iDTA sympathetic ganglia compared to controls at 5 days post-tamoxifen injection (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>). To identify cell types undergoing apoptosis, we performed TUNEL labeling together with immunostaining for Sox10, a transcription factor expressed in satellite glia (<xref ref-type="bibr" rid="bib12">Britsch et al., 2001</xref>), and TrkA, a sympathetic neuron marker (<xref ref-type="bibr" rid="bib24">Fagan et al., 1996</xref>). We found a twofold increase in the number of TUNEL<sup>+</sup>;Sox10<sup>+</sup> cells in BLBP:iDTA ganglia compared to controls at 5 days post-tamoxifen injection (5 dpi) (<xref ref-type="fig" rid="fig1">Figure 1E–G</xref>). Although there was a trend toward enhanced neuronal apoptosis, the number of TUNEL<sup>+</sup>;TrkA<sup>+</sup> sympathetic neurons in BLBP:iDTA ganglia was not statistically different from that in controls at this stage (<xref ref-type="fig" rid="fig1">Figure 1F–H</xref>). Despite increased glial apoptosis at 5 dpi, there was no significant loss of satellite glial cells at this time as assessed by quantification of Sox2-immunoreactive cells (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A and B</xref>), where Sox2 is another transcription factor expressed in satellite glia (<xref ref-type="bibr" rid="bib48">Koike et al., 2014</xref>). However, at 5 dpi, we did observe fewer Sox2-positive glial cells juxtaposed to cell bodies of individual sympathetic neurons in mutant ganglia (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2 A and C</xref>), suggesting that unhealthy/dying satellite glia lose their contacts with neuronal soma. By 14 days post-tamoxifen injection (14 dpi), however, there was a pronounced loss of Sox2-labeled satellite glial cells (54.2% decrease) in sympathetic ganglia from BLBP:iDTA mice (<xref ref-type="fig" rid="fig1">Figure 1I and J</xref>). To confirm ablation of Sox2-positive cells, rather than downregulated Sox2 expression in mutant ganglia, we generated binary images of Sox2-labeled cells by filtering and thresholding using ImageJ. This method allowed us to simply record the presence or absence of cells in the images in a manner independent of pixel values. Quantification of binary images revealed a substantial decrease in the number of Sox2-labeled cells (33% decrease) in BLBP:iDTA ganglia compared to controls at 14 dpi (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2D and F</xref>). Of note, this 33% decrease is lower than the 54% loss quantified using Sox2 immunofluorescence (<xref ref-type="fig" rid="fig1">Figure 1J</xref>). Assessing binary images from the 5 dpi time point indicated that there was no significant loss of Sox2-labeled cells at this stage (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2E and G</xref>), consistent with quantifications based on Sox2-immunofluorescence (see <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>). As an additional measure to visualize sympathetic neurons and associated satellite glial cells in a manner that does not rely on fluorescence, we labeled sympathetic neurons using TH DAB (3,3'-diaminobenzidine) immunohistochemistry and visualized satellite glia nuclei abutting TH-positive neuronal cell bodies based on their distinctive appearance and location using hematoxylin staining. We observed a significant loss of glial nuclei associated with soma of individual sympathetic neurons in BLBP:iDTA mice compared to control mice at 14 dpi (<xref ref-type="fig" rid="fig1">Figure 1K and L</xref>). Together, these results indicate that satellite glia are undergoing apoptosis by 5 dpi, and by 14 dpi, there is a substantial loss of glial cells in BLBP:iDTA ganglia. Further, consistent with cell loss at 14 dpi, we found a pronounced downregulation of several satellite glia-specific transcripts, including <italic>Fabp7</italic>, <italic>Fasn</italic>, <italic>Apoe</italic>, and <italic>Kcnj10</italic> (<xref ref-type="bibr" rid="bib58">Mapps et al., 2022</xref>), in BLBP:iDTA sympathetic ganglia at this time as revealed by quantitative PCR (qPCR) analyses (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2H</xref>).</p><p>In BLBP:iDTA ganglia, we did not find increased macrophage infiltration as assessed by quantification of IBA-1-labeled cells (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A and B</xref>). It remains to be determined whether satellite glia loss triggers increased macrophage reactivity or phagocytosis. Further, EdU labeling indicated that satellite glial cells do not undergo increased proliferation as a compensatory or injury-induced response after DTA expression (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C and D</xref>). Together, these results suggest that DTA-induced ablation of satellite glia is not accompanied by increased macrophage density or glial proliferation in mutant sympathetic ganglia.</p></sec><sec id="s2-2"><title>Satellite glia depletion impairs noradrenergic enzyme expression, metabolism, and survival of sympathetic neurons</title><p>When performing TH immunostaining to visualize sympathetic neuron morphology, we noticed a striking downregulation of TH immunoreactivity in sympathetic neuronal cell bodies from BLBP:iDTA mice. TH is the rate-limiting enzyme in the biosynthesis of NE, the classical sympathetic neurotransmitter. qPCR analyses revealed a drastic downregulation in <italic>Th</italic> and <italic>Dopamine Beta-Hydroxylase</italic> (DBH) transcript levels, (88 and 99% decrease, respectively) (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>). DBH converts dopamine to NE in the NE biosynthetic pathway. Thus, satellite glia maintain noradrenergic enzymes in sympathetic neurons.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Neuronal defects in norepinephrine (NE) biosynthesis, metabolism, and survival in satellite glia-depleted mice.</title><p>(<bold>A</bold>) Tyrosine hydroxylase (TH) expression is downregulated in BLBP:iDTA sympathetic neurons. Insets also show atrophied neuronal cell bodies in mutant ganglia compared to controls. Scale bar: 100 μm for upper panels and 30 μm for insets. (<bold>B</bold>) Transcripts for <italic>Th</italic> and <italic>DBH</italic>, key enzymes in norepinephrine biosynthesis, are decreased in BLBP:iDTA SCG relative to control ganglia. Data are presented as means ± SEM from superior cervical ganglia (SCG) collected from n = 3–4 animals per genotype. ***p&lt;0.001, ****p&lt;0.0001, <italic>t</italic>-test with Bonferroni–Dunn’s correction. (<bold>C</bold>) Histogram shows a greater distribution of smaller soma sizes in mutant neurons compared to controls. Results are means ± SEM from n = 6–8 animals per genotype, **p&lt;0.01, two-way ANOVA with Bonferroni’s correction. (<bold>D</bold>) Reduced soma sizes, represented as median values for soma areas (μm<sup>2</sup>), of sympathetic neurons from BLBP:iDTA mice compared to controls at 5 dpi. Values are means ± SEM from n = 8 control and 6 mutant animals, *p&lt;0.05, <italic>t</italic>-test. (<bold>E</bold>) Immunostaining shows reduced p-S6 levels in BLBP:iDTA ganglia. Scale bar:100 μm. (<bold>F, G</bold>) Cell counts in Nissl-stained SCG tissue sections show reduced sympathetic neuron numbers in satellite glia-depleted mice 14 dpi. Results are means ± SEM from n = 4 control and 5 mutant animals. **p&lt;0.01, <italic>t-</italic>test.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Raw data for neuronal morphology and survival.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74295-fig2-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74295-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Neuronal morphology and signaling in BLBP:iDTA mice.</title><p>(<bold>A</bold>) Immunostaining shows reduced phospho-4E-BP1 expression in BLBP:iDTA sympathetic neurons compared to controls at 5 dpi. Scale bar: 100 μm. (<bold>B</bold>) Sympathetic neuron numbers in satellite glia-depleted mice are similar to control values at 5 dpi. Results are mean ± SEM from n = 5 control and 4 mutant animals, n.s., not significant, <italic>t</italic>-test. (<bold>C</bold>) Sympathetic axon innervation of the heart is unaffected in adult BLBP:iDTA mice based on iDISCO-based tissue clearing and wholemount tyrosine hydroxylase (TH) immunostaining. Scale bar: 100 µm. (<bold>D, E</bold>) Quantification of axon length and branches in the heart in BLBP:iDTA and control mice. Data are mean ± SEM from n = 4 control and 5 mutant animals, n.s., not significant, <italic>t</italic>-test.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Raw data for neuronal morphology and survival.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74295-fig2-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74295-fig2-figsupp1-v3.tif"/></fig></fig-group><p>Using TH immunohistochemistry, we also observed pronounced atrophy of neuronal cell bodies in sympathetic ganglia after satellite glia loss (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Quantification of soma sizes revealed significantly reduced neuronal soma areas in satellite glia-depleted mice, with a greater distribution of smaller-sized cell bodies in mutant ganglia relative to controls (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Median values for soma areas are 162 ± 17 μm<sup>2</sup> for control neurons vs 118 ± 7.1 μm<sup>2</sup> for mutant neurons (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Since the PI3K/Akt/mTOR pathway is a known regulator of neuronal soma size (<xref ref-type="bibr" rid="bib52">Kwon et al., 2006</xref>; <xref ref-type="bibr" rid="bib83">van Diepen et al., 2009</xref>; <xref ref-type="bibr" rid="bib89">Zhou et al., 2009</xref>), we assessed expression of key downstream effectors of the mTOR pathway, phosphorylated ribosomal protein 6 (p-S6) and phosphorylated eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (p-4-EBP1) (<xref ref-type="bibr" rid="bib63">Meyuhas, 2008</xref>; <xref ref-type="bibr" rid="bib72">Saxton and Sabatini, 2017</xref>), using immunostaining. We observed a dramatic reduction in p-S6 and p-4-EBP1 immunoreactivity in satellite glia-depleted ganglia (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). These results suggest that satellite glia promote soma growth, in part, via regulating mTOR signaling in sympathetic neurons.</p><p>Given the soma atrophy, we asked whether satellite glia ablation affects neuron survival. At 5 dpi, sympathetic neuron numbers in BLBP:iDTA mice were not significantly different from that in control littermates (12,240 ± 1514 in mutant vs. 14,200 ± 1005 in control mice) as revealed by Nissl staining and quantification of cell counts in tissue sections from SCG (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). However, by 14 dpi, we found a marked loss of sympathetic neurons (24% decrease) in satellite glia-ablated ganglia (11,790 ± 706 mutant neurons vs. 15,460 ± 734 control neurons) (<xref ref-type="fig" rid="fig2">Figure 2F and G</xref>). Despite the decrease in neuronal numbers, sympathetic axon innervation was maintained in target organs in BLBP:iDTA mice, when assessed by wholemount TH immunostaining in iDISCO-cleared tissues and light sheet microscopy (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C–E</xref>). Intriguingly, TH levels in mutant axons appeared to be similar to that in controls (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C–E</xref>), despite the marked reduction in <italic>Th</italic> mRNA and protein in neuronal cell bodies residing in the ganglia (see <xref ref-type="fig" rid="fig2">Figure 2A and B</xref>), suggesting differential regulation of TH distribution in neuronal soma <italic>vs</italic>. axons.</p><p>Together, these results indicate that satellite glia provide trophic and metabolic support to adult sympathetic neurons and regulate noradrenergic biosynthetic machinery, specifically in neuronal cell bodies.</p></sec><sec id="s2-3"><title>Sympathetic activity is elevated in satellite glia-depleted mice</title><p>Given neuronal deficits with satellite glia depletion, we sought to determine whether autonomic responses were impacted in BLBP:iDTA mice. In mammals, pupil size can serve as a noninvasive and rapid readout for autonomic function (<xref ref-type="bibr" rid="bib62">McDougal and Gamlin, 2015</xref>). Pupil size is modulated by a balance of sympathetic vs. parasympathetic activity, with the sympathetic component regulating pupil dilation while parasympathetic activity controls pupil constriction (<xref ref-type="bibr" rid="bib62">McDougal and Gamlin, 2015</xref>). To measure basal pupil size, control and BLBP:iDTA mice were dark-adapted for 2 days, and pupil sizes recorded for 5–10 s in the dark in non-anesthetized mice (<xref ref-type="bibr" rid="bib43">Keenan et al., 2016</xref>). Surprisingly, despite the neuronal loss and downregulated noradrenergic biosynthetic enzymes in neuronal soma, we observed increased basal pupil areas in BLBP:iDTA mice compared to controls (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). To ask whether this phenotype is due to decreased parasympathetic activity, we measured pupil constriction in response to increasing light intensities, ranging from 0.01 to 1000 lux, administered for 30 s. Light onset at 0.1 lux or higher resulted in rapid constriction with greater constrictions at higher light intensities in both BLBP:iDTA and control mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). The intensity responses were virtually identical for the two groups (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). These results suggest that parasympathetic function is intact in BLBP:iDTA mice and that the enlarged pupil areas likely reflect an increase in sympathetic tone with the loss of satellite glia.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Elevated sympathetic activity in satellite glia-depleted mice.</title><p>(<bold>A, B</bold>) Dark-adapted BLBP:iDTA mice have increased basal pupil size compared to control littermates. Results are presented as mean ± SEM from n = 6 control and 5 mutant animals. *p&lt;0.05, <italic>t</italic>-test. (<bold>C</bold>) BLBP:iDTA mice exhibit elevated heart rate, relative to controls. ECGs were recorded continuously in conscious mice for 7 days, although only data for fourth to seventh days after insertion of lead implants are included in the analysis. Results are presented as mean ± SEM from n = 5 control and 6 mutant animals. *p&lt;0.05, **p&lt;0.01, two-way ANOVA with Bonferroni’s correction. (<bold>D</bold>) Average heart rate over fourth to seventh days after lead implantation. Results are mean ± SEM from n = 5 control and 6 mutant animals. **p&lt;0.01, <italic>t</italic>-test. (<bold>E, F</bold>) 6-Hydroxydopamine (6-OHDA) administration (150 mg/kg, i.p.) prevents elevated heart rate in BLBP:iDTA mice. Results are mean ± SEM from n = 5 control and 4 mutant animals, n.s, not significant, <italic>t</italic>-test. (<bold>G</bold>) Increased circulating norepinephrine levels in BLBP:iDTA mice. Results are mean ± SEM from n = 11 control and 13 mutant animals. *p&lt;0.05, <italic>t</italic>-test. (<bold>H, I</bold>) Increased c-Fos-positive sympathetic neurons in mutant ganglia. Quantification of c-Fos<sup>+</sup>;TH<sup>+</sup> sympathetic neurons as a % of total number of TH<sup>+</sup> sympathetic neurons. Results are mean ± SEM from n = 3 control and 4 mutant animals. *p&lt;0.05, <italic>t</italic>-test.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Raw data for pupil size and heart rate in mice, NE secretion, and c-Fos expression.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74295-fig3-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74295-fig3-v3.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Autonomic function analyses in BLBP:iDTA mice.</title><p>(<bold>A</bold>) Parasympathetic activity is normal in satellite glia-depleted mice as assessed by measuring pupil constriction in response to increasing light intensities. Data are mean ± SEM from n = 5 control and 6 mutant animals, two-way ANOVA with Bonferroni’s correction. (<bold>B</bold>) Representative heart rate recordings over time show decreased heart rate variability in BLBP:iDTA mice compared to controls. (<bold>C, D</bold>) Tamoxifen treatment (180 mg/kg body weight for five consecutive days) does not alter heart rate in wild-type C57Bl/6J mice or control <italic>ROSA26<sup>eGFP-DTA</sup></italic> mice without Cre. Values are mean ± SEM from n = 5 vehicle- and 4 tamoxifen-injected animals, n.s., not significant, <italic>t</italic>-test. (<bold>E</bold>) Downregulated adrenergic receptor expression in cardiac tissue as assessed by qPCR analysis. Data are mean ± SEM from n = 6 control and 5 mutant animals, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, <italic>t</italic>-test with Bonferroni–Dunn’s correction.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Raw data for pupil and heart rate analyses in mice and adrenergic receptor expression in heart tissue.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74295-fig3-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74295-fig3-figsupp1-v3.tif"/></fig></fig-group><p>As a second and independent assessment of autonomic function, we measured heart rate and heart rate variability (HRV) using electrocardiogram (ECG) recordings in mice (<xref ref-type="bibr" rid="bib80">Thireau et al., 2008</xref>). Increased sympathetic activity results in an accelerated heart rate and decreased HRV, defined as the variation in time intervals between consecutive heartbeats (<xref ref-type="bibr" rid="bib80">Thireau et al., 2008</xref>). Strikingly, BLBP:iDTA mice exhibited increased heart rates (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref>) and decreased HRV (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>) compared to controls. Tamoxifen injections had no effect on heart rate in wild-type C57BL/6J mice or control <italic>ROSA26<sup>eGFP-DTA</sup></italic> mice that do not express Cre (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C and D</xref>).</p><p>To directly test the involvement of sympathetic neurons in the heart defect observed in BLBP:iDTA mice, we chemically ablated sympathetic nerves using 6-hydroxydopamine (6-OHDA), which selectively destroys sympathetic, but not parasympathetic or sensory nerves (<xref ref-type="bibr" rid="bib11">Borden et al., 2013</xref>; <xref ref-type="bibr" rid="bib49">Kostrzewa and Jacobowitz, 1974</xref>). Further, 6-OHDA does not cross the blood–brain barrier after intraperitoneal injections in adult animals, restricting its actions to the periphery (<xref ref-type="bibr" rid="bib49">Kostrzewa and Jacobowitz, 1974</xref>). Ablation of sympathetic nerves prevented the augmented heart rate in BLBP:iDTA mice (<xref ref-type="fig" rid="fig3">Figure 3E and F</xref>), suggesting the dysfunction of peripheral sympathetic neurons as the primary contributor to the cardiac defect in satellite glia-ablated mice.</p><p>To understand the molecular and/or cellular basis for enhanced sympathetic activity in satellite glia-depleted mice, we measured circulating NE levels and observed a significant 1.6-fold increase in BLBP:iDTA mice compared to controls (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). These results suggest that, despite the downregulation of NE biosynthetic machinery in neuronal cell bodies (see <xref ref-type="fig" rid="fig2">Figure 2A and B</xref>), neurotransmitter secretion is augmented in sympathetic axons and/or its reuptake/degradation decreased, in satellite glia-depleted mice. NE acts through α- and β-adrenergic receptors in target tissues. Heightened sympathetic activity and increased circulating NE elicits the compensatory downregulation of adrenergic receptor levels and activities in target tissues (<xref ref-type="bibr" rid="bib22">Eschenhagen, 2008</xref>). We found significantly decreased expression of <italic>Adrb1</italic>, the major adrenergic receptor for NE signaling in the heart (<xref ref-type="bibr" rid="bib17">de Lucia et al., 2018</xref>), as well as <italic>Adrb2</italic> and <italic>Adra2c</italic>, using qPCR analyses of cardiac tissue (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>). Lastly, immunostaining for c-Fos, an immediate early transcription factor that serves as a reporter of neuronal activity (<xref ref-type="bibr" rid="bib77">Sheng and Greenberg, 1990</xref>), revealed a striking eightfold increase in the number of c-Fos-positive sympathetic neurons in BLBP:iDTA ganglia compared to controls (<xref ref-type="fig" rid="fig3">Figure 3H and I</xref>).</p><p>Together, these results indicate that satellite glia depletion results in elevated sympathetic neuron activity, impaired NE homeostasis, and autonomic behavioral defects in mice.</p></sec><sec id="s2-4"><title>Satellite glia-specific deletion of <italic>Kir4.1</italic> disrupts sympathetic neuron activity</title><p>Kir4.1 is a glial-specific, inwardly rectifying K<sup>+</sup> channel that shows the highest expression in astrocytes and satellite glia (<xref ref-type="bibr" rid="bib36">Hanani and Spray, 2020</xref>; <xref ref-type="bibr" rid="bib69">Olsen et al., 2015</xref>; <xref ref-type="bibr" rid="bib85">Vit et al., 2008</xref>). <italic>Kcnj10</italic> mRNA for Kir4.1 is highly enriched in satellite glia (approximately threefold enriched) compared to other ganglionic cell types based on our analysis of data sets obtained from single-cell RNA-sequencing of sympathetic and sensory ganglia from adult mice (postnatal days 30–45) (<xref ref-type="bibr" rid="bib58">Mapps et al., 2022</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Co-immunolabeling for Kir4.1 and m-EGFP in <italic>Fabp7-CreER2;ROSA26<sup>mEGFP</sup></italic> reporter mice revealed co-localization of the two signals in sympathetic ganglia (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). Further, in BLBP:iDTA sympathetic ganglia, we observed a pronounced decrease in <italic>Kcnj10</italic> mRNA compared to controls as assessed by qPCR analysis (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2H</xref>) and single-molecule fluorescence in situ hybridization (smFISH) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). Our results are consistent with previous studies that <italic>Kcnj10</italic> is enriched in satellite glial cells (<xref ref-type="bibr" rid="bib4">Avraham et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Hanani and Spray, 2020</xref>; <xref ref-type="bibr" rid="bib85">Vit et al., 2008</xref>).</p><p>In mice, global or tissue-specific Kir4.1 deletion results in impaired K<sup>+</sup> and glutamate homeostasis, loss of glial K<sup>+</sup> conductance, neuronal excitability, epileptic seizures, and pain-like behaviors (<xref ref-type="bibr" rid="bib16">Cui et al., 2018</xref>; <xref ref-type="bibr" rid="bib18">Djukic et al., 2007</xref>; <xref ref-type="bibr" rid="bib69">Olsen et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Tang et al., 2010</xref>; <xref ref-type="bibr" rid="bib85">Vit et al., 2008</xref>). To ask whether impaired Kir4.1 function might contribute to the neuronal defects observed in satellite glia-ablated mice, we generated satellite glia-specific Kir4.1 knockout mice (Kir4.1 cKO) by crossing <italic>Fabp7-CreER2</italic> mice to <italic>Kcnj10</italic> floxed mice (<xref ref-type="bibr" rid="bib18">Djukic et al., 2007</xref>). <italic>Fabp7-CreER2; Kcnj10<sup>fl/fl</sup></italic> (henceforth called Kir4.1 cKO) mice were treated with vehicle or tamoxifen for five consecutive days to conditionally delete Kir4.1 from satellite glial cells. Expression of Kir4.1, visualized by immunofluorescence, was significantly reduced in Kir4.1 cKO sympathetic ganglia (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), and qPCR analysis indicated a 76% decrease in <italic>Kcnj10</italic> transcript levels (<xref ref-type="fig" rid="fig4">Figure 4B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Satellite glia-specific Kir4.1 loss impairs norepinephrine (NE) enzyme expression and neuron activity.</title><p>(<bold>A, B</bold>) Reduced Kir4.1 protein and transcript (<italic>Kcnj10</italic>) in Kir4.1 cKO mice. Scale bar: 30 μm. Data in (<bold>B</bold>) are mean ± SEM from n = 3 animals per genotype, **p&lt;0.01, <italic>t</italic>-test. (<bold>C, D</bold>) Sox2-positive satellite glial cell numbers are unaffected in Kir4.1 cKO SCG. Arrows indicate Sox2-labeled nuclei of satellite glia associated with sympathetic neuron cell bodies. Arrowheads indicate Sox2-labeled satellite glia that are not adjacent to neuronal soma. Scale bar: 30 μm. Data are presented as mean ± SEM from n = 3 animals per genotype, n.s., not significant, <italic>t</italic>-test. (<bold>E, F</bold>) Kir4.1 deletion in satellite glia results in an increase in c-Fos-positive sympathetic neurons. Quantification of c-Fos<sup>+</sup>;TH<sup>+</sup> sympathetic neurons as a % of total number of TH<sup>+</sup> sympathetic neurons. Scale bar: 100 μm. Quantifications are mean ± SEM from n = 3 animals per genotype, *p&lt;0.05, <italic>t</italic>-test. (<bold>G, H</bold>) Downregulation of NE biosynthetic enzymes, TH and DBH, in Kir4.1 cKO sympathetic ganglia. Results are mean ± SEM from n = 3–5 animals per genotype, *p&lt;0.05, ****p&lt;0.0001, <italic>t</italic>-test with Bonferroni’s correction.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Raw data for glia and neuron cell counts and gene expression changes in Kir4.1 mutant and control mice.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74295-fig4-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74295-fig4-v3.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Kir4.1 expression and analyses of satellite glia in <italic>Kir4.1 cKO</italic> mice.</title><p>(<bold>A</bold>) <italic>Kcnj10</italic> mRNA is enriched in satellite glia compared to other ganglionic cell types based on single-cell RNA-sequencing analysis of sympathetic and sensory ganglia from adult mice (postnatal days 30–45) (<xref ref-type="bibr" rid="bib58">Mapps et al., 2022</xref>). Expression is normalized to cell counts for individual ganglionic cell types. (<bold>B</bold>) Single-molecule fluorescence in situ hybridization (smFISH) shows decreased <italic>Kcnj10</italic> mRNA in BLBP:iDTA sympathetic ganglia. Scale bar: 100 µm. (<bold>C, D</bold>) Binary images and quantifications of Sox2-labeled cells in Kir4.1 cKO and control sympathetic ganglia. Scale bar: 30 µm. Data are presented as mean ± SEM from n = 3 control and 4 mutant animals, n.s., not significant, <italic>t</italic>-test. (<bold>E</bold>) <italic>Fabp7</italic> mRNA levels are unaltered in Kir4.1 cKO sympathetic ganglia as assessed by qPCR analysis. Data are mean ± SEM from n = 4 control and 3 mutant animals, n.s., not significant, <italic>t</italic>-test. (<bold>F</bold>) Brain lipid binding protein (BLBP) immunostaining shows that BLBP protein expression and satellite glial morphologies are not altered in <italic>Kir4.1 cKO</italic> sympathetic ganglia. Scale bar: 30 µm.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Raw data for glia cell counts and gene expression changes in Kir4.1 mutant and control mice.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74295-fig4-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74295-fig4-figsupp1-v3.tif"/></fig></fig-group><p>Loss of Kir4.1 did not alter satellite glial numbers in sympathetic ganglia as assessed by quantification of Sox2-positive cells (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C and D</xref>). Kir4.1 deletion also did not affect <italic>Fabp7</italic> (BLBP) expression in satellite glia assessed by qPCR analysis and immunostaining (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E and F</xref>). BLBP immunostaining also indicated that the characteristic ring-like glial organization around neuronal soma was not perturbed in Kir4.1 cKO sympathetic ganglia (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F</xref>). However, we observed a marked increase in the number of c-Fos-positive cells in Kir4.1 cKO SCGs compared to controls (<xref ref-type="fig" rid="fig4">Figure 4E and F</xref>). The majority of c-Fos-positive cells in Kir4.1 cKO ganglia appeared to be neurons based on their morphology. Intriguingly, despite increased c-Fos-positive sympathetic neurons, Kir4.1 deletion resulted in downregulated expression of noradrenergic biosynthetic enzymes, TH and DBH, in neuronal cell bodies (<xref ref-type="fig" rid="fig4">Figure 4C, G, and H</xref>), similar to the phenotype observed with satellite glia depletion.</p><p>Together, these results suggest that satellite glial cells control sympathetic neuron activity and noradrenergic enzyme expression via Kir4.1-dependent regulation of the neuronal microenvironment.</p></sec><sec id="s2-5"><title>Satellite glia-specific deletion of Kir4.1 elicits neuron atrophy and apoptosis</title><p>We next addressed the relevance of satellite glia Kir4.1 expression in sympathetic neuron viability. Quantification of soma sizes revealed that neurons undergo atrophy in Kir4.1 cKO sympathetic ganglia (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), similar to the defect observed with DTA-induced loss of satellite glia. Soma areas from tissue sections, represented as median values, were 155 ± 13 μm<sup>2</sup> for control neurons vs. 118 ± 3.6 μm<sup>2</sup> for mutant neurons (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Kir4.1 loss in satellite glial cells also elicited a pronounced decrease in the levels of p-S6 and p-4-EBP1, two well-established downstream effectors of mTOR activity (<xref ref-type="bibr" rid="bib63">Meyuhas, 2008</xref>; <xref ref-type="bibr" rid="bib72">Saxton and Sabatini, 2017</xref>), in sympathetic neurons (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>), similar to the effects of satellite glia ablation (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Notably, we observed an eightfold increase in apoptotic cells in Kir4.1 cKO sympathetic ganglia using TUNEL labeling at 14 days post-tamoxifen injection (<xref ref-type="fig" rid="fig5">Figure 5D and E</xref>). The apoptotic cells were primarily sympathetic neurons based on co-labeling for TUNEL and TrkA (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B and C</xref>). We did not observe increased apoptosis of satellite glial cells in Kir4.1 cKO sympathetic ganglia compared to controls (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D and E</xref>), consistent with results that the number of Sox2-positive satellite glia was not altered by Kir4.1 deletion (see <xref ref-type="fig" rid="fig4">Figure 4C and D</xref>). Consistent with enhanced neuronal apoptosis, we observed a 22% decrease in sympathetic neuron numbers in Kir4.1 cKO sympathetic ganglia by 2 weeks after tamoxifen injections (<xref ref-type="fig" rid="fig5">Figure 5F and G</xref>). Similar to the findings in BLBP:iDTA mice, sympathetic axon innervation and axonal TH expression were similar between Kir4.1 cKO mice and controls (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F and G</xref>), despite the decrease in sympathetic neuron numbers and downregulated TH expression in neuronal cell bodies. Together, these results highlight that Kir4.1 is necessary for the survival of adult sympathetic neurons.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Defects in neuron viability in Kir4.1 cKO mice.</title><p>(<bold>A</bold>) Kir4.1 <italic>cKO</italic> sympathetic neurons have smaller soma sizes compared to control neurons. Results are mean ± SEM from n = 3 control and 5 mutant mice, ***p&lt;0.001, two-way ANOVA with Bonferroni’s correction. (<bold>B</bold>) Reduced soma size, represented as median values of soma areas (μm<sup>2</sup>) of Kir4.1 cKO sympathetic neurons compared to controls. Values are mean ± SEM from n = 3 control and 5 mutant animals, *p&lt;0.05, <italic>t</italic>-test. (<bold>C</bold>) Decreased mTOR signaling based on p-S6 immunostaining in Kir4.1 cKO sympathetic ganglia. Scale bar: 100 μm. (<bold>D</bold>) TUNEL labeling shows increased apoptosis in Kir4.1 cKO SCG (outlined in red dashed line). Scale bar: 100 μm. (<bold>E</bold>) Quantification of apoptotic cells in control and mutant sympathetic ganglia from n = 3 mice per genotype. Data presented as mean ± SEM **p&lt;0.01, <italic>t</italic>-test. (<bold>F, G</bold>) Decreased sympathetic neuron numbers in Kir4.1 cKO mice based on Nissl-staining and cell counts in sympathetic ganglia tissue sections. Results are mean ± SEM from n = 3 control and 4 mutant animals. *p&lt;0.05, <italic>t</italic>-test. (<bold>H</bold>) Heart rate is unaffected by Kir4.1 deletion from satellite glia. Results are mean ± SEM from n = 5 control and 6 mutant animals, two-way ANOVA with Bonferroni’s correction. (<bold>I</bold>) Average heart rate over days 4–7 post-lead implantation. Results are mean ± SEM from n = 5 control and 6 mutant animals. n.s., not significant.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Raw data for neuron morphology and heart rate in Kir4.1 mutant and control mice.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74295-fig5-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74295-fig5-v3.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Additional morphology and functional analyses in Kir4.1 cKO mice.</title><p>(<bold>A</bold>) Reduced p-4E-BP1 levels as shown by immunostaining in Kir4.1 cKO sympathetic neurons compared to controls. Scale bar: 100 μm. (<bold>B</bold>) Increased neuronal apoptosis in Kir4.1 cKO ganglia as shown by TrkA immunostaining (magenta) and TUNEL labeling (green). Arrowheads indicate TUNEL<sup>+</sup>;TrkA<sup>+</sup> sympathetic neurons. Scale bar: 30 µm. (<bold>C</bold>) Quantification of TUNEL<sup>+</sup>;TrkA<sup>+</sup> neurons expressed as a % of total number of TrkA<sup>+</sup> neurons. Data are presented as mean ± SEM from n = 4 control and 5 mutant mice, *p&lt;0.05, <italic>t</italic>-test. (<bold>D</bold>) Glial apoptosis is unaltered with Kir4.1 loss, assessed by Sox10 immunostaining (green) and TUNEL labeling (red). Arrowheads indicate TUNEL<sup>+</sup>; Sox10<sup>+</sup> cells. Scale bar 30 µm. (<bold>E</bold>) Quantification of TUNEL<sup>+</sup>;Sox10<sup>+</sup> glial cells expressed as a % of the total number of Sox10<sup>+</sup> satellite glial cells. Data are presented as mean ± SEM from n = 6 control and 4 mutant mice, n.s, not significant, <italic>t</italic>-test. (<bold>F</bold>) Tyrosine hydroxylase (TH) immunostaining shows normal sympathetic axon innervation in Kir4.1 cKO salivary glands. Scale bar: 100 µm. (<bold>G</bold>) Quantification of sympathetic innervation density in salivary glands. Data are mean ± SEM from n = 6 control and 5 mutant mice, n.s, not significant, <italic>t</italic>-test. (<bold>H, I</bold>) Basal pupil areas are unaffected by satellite glia-specific Kir4.1 deletion. Data are mean ± SEM from n = 10 control and 9 mutant animals, two-way ANOVA with Bonferroni’s correction. (<bold>J</bold>) Circulating norepinephrine (NE) levels are unaltered with Kir4.1 deletion from satellite glia. Data are mean ± SEM from n = 7 control and 12 mutant animals, n.s., not significant, <italic>t</italic>-test. (<bold>K</bold>) Pupil constriction in response to light, indicative of parasympathetic activity, is normal in Kir4.1 cKO mice. Data are mean ± SEM from n = 5 control and 6 mutant animals, two-way ANOVA with Bonferroni’s correction.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Raw data for neuron and glia morphology, and pupil analyses in Kir4.1 mutant and control mice.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-74295-fig5-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-74295-fig5-figsupp1-v3.tif"/></fig></fig-group><p>We next asked whether satellite glia-specific Kir4.1 deletion recapitulates the autonomic defects observed in BLBP:iDTA mice. Measurements of basal pupil size, heart rate, and circulating NE levels indicated that these parameters were not significantly altered in Kir4.1 cKO mice (<xref ref-type="fig" rid="fig5">Figure 5H and I</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1H–J</xref>), despite increased neuronal activity as assessed by c-Fos immunoreactivity (see <xref ref-type="fig" rid="fig4">Figure 4E and F</xref>). Parasympathetic activity assessed by pupil constriction in response to different light intensities was also normal in Kir4.1 cKO mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1K</xref>).</p><p>Together, these results suggest that Kir4.1 deletion recapitulates the cellular phenotypes observed in BLBP:iDTA mice, notably, increased neuron activity, impaired metabolic signaling, and enhanced apoptosis. However, the deletion of a single gene, <italic>Kcnj10</italic> encoding for Kir4.1, from satellite glial cells is not sufficient to drive behavioral changes at the whole animal level as seen with genetic ablation of satellite glial cells. These results suggest that there are other satellite glia-dependent mechanisms, in addition to Kir4.1 activity, that contribute to regulation of neuronal excitability to drive circuit-level changes.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Despite decades of research on the sympathetic nervous system, satellite glia, the major glial cells in sympathetic ganglia, have remained an enigmatic component of the system. Given their specific contacts with neuronal cell bodies, satellite glia also provide the rare opportunity to study how glia support somatic compartments. Here, we show that satellite glia modulate sympathetic neuron metabolism, survival, neurotransmitter homeostasis, activity, and autonomic functions in adult mice. Together, our findings provide in vivo evidence that neurons and their surrounding glial covers are functional units in the regulation of sympathetic output.</p><p>We reveal that a key role for satellite glia is in restraining neuronal activity in mature sympathetic neurons. Depletion of satellite glia in adult mice amplifies neuronal activity, leading to increased circulating levels of NE and elevated sympathetic tone. Glia-ablated mice show enhanced pupil size and heart rate, demonstrating the necessity of these cells in the dynamic regulation of autonomic functions in conscious and freely moving animals. Our findings that satellite glia limit neuronal activity are similar to reported functions of other glial cells that encapsulate neuronal cell bodies, in particular, astrocytes (<xref ref-type="bibr" rid="bib1">Allen and Lyons, 2018</xref>), microglia (<xref ref-type="bibr" rid="bib7">Badimon et al., 2020</xref>; <xref ref-type="bibr" rid="bib15">Cserép et al., 2020</xref>), and cortex glia in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib88">Yadav et al., 2019</xref>). Inhibitory effects of satellite glia might enable sympathetic neurons to respond to a wider range of input strengths and/or serve as a neuroprotective mechanism to limit neurotoxicity under conditions of stress or pathology.</p><p>How do satellite glia limit sympathetic neuron activity? The enhanced neuronal c-Fos signals in Kir4.1 cKO and satellite glia-ablated mice suggest that glial regulation of ion homeostasis, specifically, K<sup>+</sup> clearance, is a key mechanism that contributes to inhibition of neuronal activity. Electrophysiological analyses show that satellite glia have high K<sup>+</sup> conductance, which is almost exclusively dependent on Kir4.1 expression (<xref ref-type="bibr" rid="bib79">Tang et al., 2010</xref>). Satellite glial cells are also coupled to one another through gap junctions (<xref ref-type="bibr" rid="bib40">Huang et al., 2005</xref>; <xref ref-type="bibr" rid="bib45">Kim et al., 2016</xref>). RNAi-mediated knockdown of Kir4.1 or Connexin 43, a gap junction protein, enhances excitability of sensory neurons and evokes nociceptive responses in rats (<xref ref-type="bibr" rid="bib67">Ohara et al., 2008</xref>; <xref ref-type="bibr" rid="bib85">Vit et al., 2008</xref>; <xref ref-type="bibr" rid="bib67">Ohara et al., 2008</xref>; <xref ref-type="bibr" rid="bib85">Vit et al., 2008</xref>). Together, these studies suggest that satellite glia are capable of taking up extracellular K<sup>+</sup>, distributing them throughout a glial syncytium via gap junction coupling, and extruding ions in regions of low K<sup>+</sup> concentration, in a process called ‘spatial K<sup>+</sup> buffering’ (<xref ref-type="bibr" rid="bib50">Kuffler, 1967</xref>; <xref ref-type="bibr" rid="bib79">Tang et al., 2010</xref>), similar to astrocyte functions in the CNS (<xref ref-type="bibr" rid="bib47">Kofuji and Newman, 2004</xref>). Even slight elevations in extracellular K<sup>+</sup> in the neuronal microenvironment, due to loss of glial Kir4.1, are likely to elicit neuronal depolarization and activation (<xref ref-type="bibr" rid="bib16">Cui et al., 2018</xref>; <xref ref-type="bibr" rid="bib39">Haydon, 2001</xref>). However, Kir4.1 may also function via additional mechanisms to modulate neuronal excitability. For example, Kir4.1 is a major contributor to the hyperpolarized resting membrane potential of satellite glia (<xref ref-type="bibr" rid="bib79">Tang et al., 2010</xref>). Depolarization of satellite glia, induced by loss of Kir4.1, could likely affect voltage-dependent processes in these cells (<xref ref-type="bibr" rid="bib79">Tang et al., 2010</xref>). Kir4.1, expressed in astrocytes, inhibits the synthesis of brain-derived neurotrophic factor (BDNF) in astrocytes (<xref ref-type="bibr" rid="bib46">Kinboshi et al., 2017</xref>; <xref ref-type="bibr" rid="bib68">Ohno et al., 2018</xref>), and astrocyte-derived BDNF has been shown to enhance neuronal activity through presynaptic mechanisms in the ventromedial hypothalamus (<xref ref-type="bibr" rid="bib2">Ameroso et al., 2022</xref>). Thus, an analogous Kir4.1-BDNF pathway might operate in satellite glia to influence neuron activity since BDNF is known to increase presynaptic input to post-ganglionic sympathetic neurons in sympathetic ganglia (<xref ref-type="bibr" rid="bib13">Causing et al., 1997</xref>).</p><p>We found that satellite glia-specific loss of Kir4.1 recapitulates all the cellular phenotypes observed in BLBP:iDTA sympathetic neurons, specifically, increased neuronal activity, diminished mTOR signaling, soma atrophy, downregulated expression of noradrenergic enzymes, and neuronal apoptosis. However, deletion of a single gene, <italic>Kcnj10</italic>, from satellite glia is not sufficient to drive behavioral changes at the whole animal level as accomplished by genetic ablation of these cells. Thus, additional glia-dependent mechanisms must contribute to neuronal excitability to drive network-level changes. Satellite glia could influence neuronal activity via regulation of ganglionic levels of acetylcholine, the major neurotransmitter released by pre-ganglionic axons. Despite previous observations that satellite glia modulate cholinergic neurotransmission in co-cultured sympathetic neurons (<xref ref-type="bibr" rid="bib21">Enes et al., 2020</xref>; <xref ref-type="bibr" rid="bib25">Feldman-Goriachnik et al., 2018</xref>), we did not detect glial transcripts involved in cholinergic signaling using single-cell RNA-sequencing of sympathetic ganglia (<xref ref-type="bibr" rid="bib58">Mapps et al., 2022</xref>). However, we do not exclude glia-mediated effects on synapse formation during development or maintenance (<xref ref-type="bibr" rid="bib21">Enes et al., 2020</xref>). Another potential mechanism could involve glial regulation of extracellular ATP and/or its breakdown products in the neuronal microenvironment (<xref ref-type="bibr" rid="bib35">Hanani, 2010</xref>). In sympathetic ganglia, ATP is largely released by innervating cholinergic pre-ganglionic axons and facilitates fast excitatory neurotransmission in post-ganglionic sympathetic neurons (<xref ref-type="bibr" rid="bib9">Boehm, 1999</xref>; <xref ref-type="bibr" rid="bib23">Evans et al., 1992</xref>; <xref ref-type="bibr" rid="bib61">McCaman and McAfee, 1986</xref>; <xref ref-type="bibr" rid="bib86">Vizi et al., 1997</xref>). Extracellular ATP is rapidly metabolized by cell-surface ectonucleotidases, which are expressed in sympathetic satellite glia (<xref ref-type="bibr" rid="bib28">Forsman and Elfvin, 1984</xref>; <xref ref-type="bibr" rid="bib66">Nacimiento et al., 1991</xref>; <xref ref-type="bibr" rid="bib86">Vizi et al., 1997</xref>). Single-cell RNA-sequencing data revealed several transcripts involved in ATP sensing, hydrolysis, and removal of breakdown products in sympathetic satellite glia, including the purinergic receptors, <italic>P2rx4, P2rx7</italic>, and <italic>P2ry12</italic>, and <italic>Entpd1,</italic> an ectoenzyme which catalyzes ATP to ADP hydrolysis, as well as <italic>Adk</italic> (<italic>adenosine kinase</italic>) (<xref ref-type="bibr" rid="bib58">Mapps et al., 2022</xref>), which is best known for mediating astrocytic uptake of extracellular adenosine in the brain (<xref ref-type="bibr" rid="bib10">Boison et al., 2010</xref>).</p><p>Our results suggest that autonomic defects observed in BLBP:iDTA mice arise primarily from defects in peripheral sympathetic neurons. We demonstrate that 6-OHDA-mediated ablation of sympathetic nerves prevents elevated heart rate in BLBP:iDTA mice. Since 6-OHDA selectively destroys sympathetic nerves (<xref ref-type="bibr" rid="bib49">Kostrzewa and Jacobowitz, 1974</xref>), these results exclude the involvement of sensory or parasympathetic neurons to the cardiac defect in BLBP:iDTA mice. Parasympathetic function in BLBP:iDTA mice appears to be unaffected since mutant mice fully constrict their pupils in response to light. BLBP is also expressed in neuronal progenitors, radial glia, and astrocytes in the CNS (<xref ref-type="bibr" rid="bib19">Ebrahimi et al., 2016</xref>; <xref ref-type="bibr" rid="bib27">Feng et al., 1994</xref>; <xref ref-type="bibr" rid="bib60">Matsumata et al., 2012</xref>). We used <italic>Fabp7-CreER2</italic> mice in an inducible manner in adult age, which allowed us to bypass the targeting of cell types during development. Although we cannot completely exclude an astrocyte contribution to autonomic defects in BLBP:iDTA mice, our results implicate a peripheral locus given the rescue of cardiovascular dysfunction in mutant mice by 6-OHDA, which does not cross the blood–brain barrier in adult mice after intraperitoneal injections (<xref ref-type="bibr" rid="bib49">Kostrzewa and Jacobowitz, 1974</xref>). Our single-cell RNA-sequencing analysis of satellite glia (<xref ref-type="bibr" rid="bib58">Mapps et al., 2022</xref>) compared to published single-cell RNA studies of astrocytes (<xref ref-type="bibr" rid="bib8">Batiuk et al., 2020</xref>) indicates an ~45-fold enrichment of <italic>Fabp7</italic> transcript in satellite glia relative to astrocytes. Further, astrocyte ablation in adult mice results in severe motor deficits, including limb paralysis, ataxia, as well as smaller body weight (<xref ref-type="bibr" rid="bib74">Schreiner et al., 2015</xref>), none of which were observed in BLBP:iDTA mice. Similarly, astrocyte-specific deletion of <italic>Kcnj10</italic> using <italic>GFAP-cre</italic> mice results in premature lethality, epileptic seizures, and severe ataxia (<xref ref-type="bibr" rid="bib18">Djukic et al., 2007</xref>), none of which were observed with Kir4.1 deletion using <italic>Fabp7-CreER2</italic> mice. Together, these results suggest that astrocytes are minimally perturbed in BLBP:iDTA and Kir4.1 cKO mice.</p><p>In a previous study, chemogenetic manipulation of satellite glia by activating a Gq-GPCR signaling pathway increased heart rate in <italic>Gfap-hM3Dq</italic> mice (<xref ref-type="bibr" rid="bib87">Xie et al., 2017</xref>). The experimental manipulation, that is, acute activation (over a time scale of minutes) of a Gq-GPCR pathway in satellite glia using DREADD ligands is different from that in our study (genetic ablation of these cells over 2 weeks), making it challenging to directly compare between the two studies. Also, how activation of a Gq-GPCR signaling pathway and calcium mobilization in satellite glia affects their physiology and function remains unknown. Additionally, we note that cellular specificity of the Cre driver lines used in the two studies is different. We, and others, have shown that <italic>Fabp7</italic> (BLBP) is a specific marker for satellite glia in this study and other work (<xref ref-type="bibr" rid="bib6">Avraham et al., 2022</xref>; <xref ref-type="bibr" rid="bib4">Avraham et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Avraham et al., 2021</xref>; <xref ref-type="bibr" rid="bib58">Mapps et al., 2022</xref>). Using single-cell sequencing, we, and others, have not detected <italic>Gfap</italic> in mouse satellite glia under normal or reactive conditions (<xref ref-type="bibr" rid="bib42">Jager et al., 2020</xref>; <xref ref-type="bibr" rid="bib58">Mapps et al., 2022</xref>; <xref ref-type="bibr" rid="bib64">Mohr et al., 2021</xref>), although it is found in satellite glia in rats (<xref ref-type="bibr" rid="bib64">Mohr et al., 2021</xref>). Nevertheless, sympathetic satellite glia, very likely, exert both excitatory and inhibitory effects on neuronal activity in a context-dependent manner, similar to astrocyte functions in the brain (<xref ref-type="bibr" rid="bib1">Allen and Lyons, 2018</xref>). Specifically, under conditions of nerve injury or inflammation, activated sensory satellite glia are known to undergo structural and functional changes, resulting in neuronal hyper-excitability (<xref ref-type="bibr" rid="bib36">Hanani and Spray, 2020</xref>). Limited studies, so far, suggest that in response to nerve damage, sympathetic satellite glia are also capable of reactive changes, specifically, enhanced gap junction-mediated coupling and increased ATP sensitivity (<xref ref-type="bibr" rid="bib26">Feldman-Goriachnik and Hanani, 2019</xref>), which, in turn, may augment neuronal activity.</p><p>An intriguing finding was that satellite glia depletion or glial deletion of Kir4.1 resulted in the loss of ~25% of adult sympathetic neurons. The exquisite dependence of sympathetic neurons on the target-derived survival factor, nerve growth factor (NGF), during development is well-documented (<xref ref-type="bibr" rid="bib31">Glebova and Ginty, 2005</xref>). However, loss of NGF signaling does not compromise the survival of adult neurons (<xref ref-type="bibr" rid="bib3">Angeletti et al., 1971</xref>; <xref ref-type="bibr" rid="bib82">Tsui-Pierchala and Ginty, 1999</xref>), and to date, the trophic mechanisms underlying adult sympathetic neuron survival in vivo remain undefined. The similar phenotypes of soma atrophy, impaired mTOR signaling, and enhanced apoptosis in adult BLBP:iDTA and Kir4.1 cKO sympathetic neurons suggest that satellite glia provide metabolic and trophic support to mature neurons, primarily, via regulation of K<sup>+</sup> homeostasis. Of note, astrocyte-specific Kir4.1 deletion also results in defects in mTOR signaling and decreased soma size, but not cell death, in a population of spinal cord motor neurons (<xref ref-type="bibr" rid="bib44">Kelley et al., 2018</xref>). Whether observed apoptosis of mature sympathetic neurons in BLBP:iDTA or Kir4.1 cKO mice is linked to hyperexcitability of a vulnerable neuronal subpopulation and/or reflects the requirement for glial-derived trophic signals remain to be defined. Further, despite enhanced sympathetic neuron activity and circulating NE levels in satellite glia-ablated mice, we observed a pronounced downregulation of NE biosynthetic machinery, specifically in neuronal cell bodies. This may reflect a compensatory response to elevated sympathetic activity upon glia loss or the need for glia-derived factors in maintenance of noradrenergic enzymes. It is also notable that satellite glia depletion resulted in soma-specific effects in sympathetic neurons, that is, TH downregulation and soma size decrease, without perturbing axonal TH levels and innervation. <italic>Th</italic> mRNA is trafficked to sympathetic axons, where it is locally translated (<xref ref-type="bibr" rid="bib30">Gervasi et al., 2016</xref>). Thus, enhanced <italic>Th</italic> mRNA trafficking and local synthesis might be a mechanism to maintain axonal TH expression and to locally regulate NE release in BLBP:iDTA sympathetic neurons.</p><p>Heightened activity of the sympathetic nervous system is a characteristic feature of several pathological conditions, specifically, chronic heart failure (<xref ref-type="bibr" rid="bib55">Malpas, 2010</xref>), arrhythmias (<xref ref-type="bibr" rid="bib38">Hasan, 2013</xref>; <xref ref-type="bibr" rid="bib75">Schwartz, 2014</xref>), hypertension (<xref ref-type="bibr" rid="bib32">Goldstein et al., 2002</xref>; <xref ref-type="bibr" rid="bib73">Schlaich et al., 2004</xref>), sleep apnea, obesity, and insulin resistance (<xref ref-type="bibr" rid="bib54">Mahfoud et al., 2011</xref>; <xref ref-type="bibr" rid="bib56">Mancia et al., 2007</xref>; <xref ref-type="bibr" rid="bib73">Schlaich et al., 2004</xref>). While sympathetic neurons, so far, have been at the center stage in considering pathological mechanisms and treatments, our study, together with other recent work (<xref ref-type="bibr" rid="bib87">Xie et al., 2017</xref>), highlights the therapeutic potential of targeting the neuron–satellite glia unit in autonomic-related diseases.</p><sec id="s3-1"><title>Quantification and statistical analyses</title><p>Information for statistical analyses for all experiments is provided in ‘Materials and methods’ and figure legends.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Fabp7-CreER2</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib59">Maruoka et al., 2011</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Gt(ROSA)26Sortm1(DTA)Jpmb/J</italic></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:006331">IMSR_JAX:006331</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>B6.129-Kcnj10tm1Kdmc/J</italic></td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Djukic et al., 2007</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:026826">IMSR_JAX:026826</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib65">Muzumdar et al., 2007</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:007576">IMSR_JAX:007576</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">C57Bl/6J</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-BLBP (mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab131137 (discontinued); RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11157091">AB_11157091</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-BLBP (rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab32423; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_880078">AB_880078</ext-link></td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Sox2 (rabbit polyclonal)</td><td align="left" valign="bottom">Active Motif</td><td align="left" valign="bottom">Cat# 39823, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2793356">AB_2793356</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-IBA1 (rabbit polyclonal)</td><td align="left" valign="bottom">WAKO</td><td align="left" valign="bottom">Cat# 019-19741; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_839504">AB_839504</ext-link></td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Kir4.1 (rabbit polyclonal)</td><td align="left" valign="bottom">Alomone Labs</td><td align="left" valign="bottom">Cat# APC-035; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2040120">AB_2040120</ext-link></td><td align="left" valign="bottom">IF (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-pS6 (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling</td><td align="left" valign="bottom">Cat# 2215S; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_916156">AB_916156</ext-link></td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-tyrosine hydroxylase (mouse monoclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# T2928; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_477569">AB_477569</ext-link></td><td align="left" valign="bottom">IF (1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-tyrosine hydroxylase (rabbit polyclonal)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">Cat# ab152; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_390204">AB_390204</ext-link></td><td align="left" valign="bottom">IF (1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-c-Fos (rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab190289; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2737414">AB_2737414</ext-link></td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Sox10 (goat polyclonal)</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">Cat# AF2864; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_442208">AB_442208</ext-link></td><td align="left" valign="bottom">IF (1:50)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-p-4E-BP-1 (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling</td><td align="left" valign="bottom">Cat# 2855T; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_560835">AB_560835</ext-link></td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TrkA (rabbit polyclonal)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">Cat# 06-674; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB">AB</ext-link>_310180</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Amersham ECL Rabbit IgG, HRP-linked whole Ab from donkey (rabbit polyclonal)</td><td align="left" valign="bottom">Cytiva</td><td align="left" valign="bottom">Cat# NA934; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB">AB</ext-link>_772206</td><td align="left" valign="bottom">DAB (1:200)</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Adra1a</italic> TaqMan Probe</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Assay ID: Mm00442668_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Adra1b</italic> TaqMan Probe</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Assay ID: Mm00431685_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Adra1d</italic> TaqMan Probe</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Assay ID: Mm01328600_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Adra2a</italic> TaqMan Probe</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Assay ID: Mm00845383_s1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Adra2b</italic> TaqMan Probe</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Assay ID: Mm00477390_s1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Adra2c</italic> TaqMan Probe</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Assay ID: Mm00431686_s1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Adrb1</italic> TaqMan Probe</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Assay ID: Mm00431701_s1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Adrb2</italic> TaqMan Probe</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Assay ID: Mm02524224_s1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Adrb3</italic> TaqMan Probe</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Assay ID: Mm02601819_g1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Eukaryotic <italic>Rn18s</italic> Endogenous Control (VIC/MGB probe, primer limited)</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# 4319413E</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Th</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">qPCR primers</td><td align="left" valign="bottom">AATCCACCACTTAGAGACCCG (‘Materials and methods’)</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Th</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">qPCR primers</td><td align="left" valign="bottom">CTTGGTGACCAGGTGGTGAC<break/>(‘Materials and methods’)</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>DBH</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">qPCR primers</td><td align="left" valign="bottom">CATCTGGATTCCCAGCAAGACT<break/>(‘Materials and methods’)</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>DBH</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">qPCR primers</td><td align="left" valign="bottom">CAGCGACTGAAATGGCTCTTCC<break/>(‘Materials and methods’)</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Rn18s</italic>_F</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Ceasrine et al., 2018</xref></td><td align="left" valign="bottom">qPCR primers</td><td align="left" valign="bottom">CGCCGCTAGAGGTGAAATTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Rn18s</italic> _R</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Ceasrine et al., 2018</xref></td><td align="left" valign="bottom">qPCR primers</td><td align="left" valign="bottom">TTGGCAAATGCTTTCGCTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Kcnj10</italic>_F</td><td align="left" valign="bottom">Harvard Primer Bank</td><td align="left" valign="bottom">PrimerBank ID:34328498a1</td><td align="left" valign="bottom">GTCGGTCGCTAAGGTCTATTACA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Kcnj10</italic>_R</td><td align="left" valign="bottom">Harvard Primer Bank</td><td align="left" valign="bottom">PrimerBank ID:34328498a1</td><td align="left" valign="bottom">GGCCGTCTTTCGTGAGGAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Fabp7<sup>CreER2</sup></italic> _F</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib59">Maruoka et al., 2011</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TACCGGTCGACAACGAGTGATGAGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Fabp7<sup>CreER2</sup></italic> _R</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib59">Maruoka et al., 2011</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GACCGACGATGCATGTTTAGCTGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gt(ROSA)26Sortm1(DTA)Jpmb/J</italic> _F</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AAAGTCGCTCTGAGTTGTTAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gt(ROSA)26Sortm1(DTA)Jpmb/J</italic> _R</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCGAAGAGTTTGTCCTCACC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>B6.129-Kcnj10tm1Kdmc/J</italic> _F</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGATCTATCTCGATTGCTGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>B6.129-Kcnj10tm1Kdmc/J</italic> _R</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCCTACTCAATGCTCTTAAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo_WT F</italic></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGC TTA AAG GCT AAC CTG ATG TG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo_WT R</italic></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGA GCG GGA GAA ATG GAT ATG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo_Mut F</italic></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCG GAT TGA TGG TAG TGG TC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo_Mut R</italic></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AAT CCA TCT TGT TCA ATG GCC GAT C</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Hydrogen peroxide solution, 30% in H<sub>2</sub>O, ACS reagent</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# 216763</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">SIGMAFAST 3,3'-Diaminobenzidine tablets, tablet, to prepare 15 mL</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# D4418-50SET</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">6-Hydrodroxydopamine hydrobromide</td><td align="left" valign="bottom">Hello Bio</td><td align="left" valign="bottom">Cat# HB1889</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Hematoxylin solution</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# GHS232</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Bouin’s solution</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# HT10132-1L</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Glycogen</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# R0551</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Maxima SYBR Green/ROX qPCR Master Mix (2×)</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# K0222</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">TaqMan Universal PCR Master Mix</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# 4304437</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Trizol</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# 15596018</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">DAPI</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Cat# 10236276001</td><td align="left" valign="bottom">(1 µg/mL)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Agarose, low EEO</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# A0576-25G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">ProLong Gold Antifade Mountant</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# P36930</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Permount Mounting Media</td><td align="left" valign="bottom">Fisher Scientific</td><td align="left" valign="bottom">Cat# SP11500</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Flouromount Mounting Media</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# F4680-25mL</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Click-iT EdU Alexa Fluor 555 Imaging Kit</td><td align="left" valign="bottom">Life Technologies</td><td align="left" valign="bottom">Cat# 10338</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">In Situ Cell Death Detection Kit, TMR red</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Cat# 12156792910</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Norepinephrine Research ELISA</td><td align="left" valign="bottom">Rocky Mountain Diagnostics, Inc</td><td align="left" valign="bottom">BA E-5200</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Superscript IV First Strand Synthesis System</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# 18091050</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Agilent Absolutely RNA Nanoprep Kit</td><td align="left" valign="bottom">Agilent</td><td align="left" valign="bottom">Cat# 400753</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNAscope Fluorescent Multiplex Assay</td><td align="left" valign="bottom">ACD</td><td align="left" valign="bottom">Cat# 320850</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNAscope Probe-Kcnj10-C3</td><td align="left" valign="bottom">ACD</td><td align="left" valign="bottom">Cat# 458831-C3</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">LabChart 8 software (ADInstruments)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.adinstruments.com/support/software">https://www.adinstruments.com/support/software</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ZEN 2012 SP1 (black edition)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.zeiss.com/microscopy/int/home.html">https://www.zeiss.com/microscopy/int/home.html</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ZEN 2012 (blue edition)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.zeiss.com/microscopy/int/home.html">https://www.zeiss.com/microscopy/int/home.html</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animal care and housing</title><p>All procedures relating to animal care and treatment conformed to The Johns Hopkins University Animal Care and Use Committee (ACUC) and NIH guidelines. Animals were group housed in a standard 12:12 light–dark cycle, except for the pupil analyses. Adult mice between 1 and 1.5 months of age, and of both sexes, were used for analyses. The following mouse lines were used in this study: C57Bl/6J (JAX:000664) mice, <italic>Fabp7-CreER2</italic> mice (<xref ref-type="bibr" rid="bib59">Maruoka et al., 2011</xref>) were generously provided by Dr. Toshihiko Hosoya (RIKEN Brain Science Institute), <italic>Kcnj10<sup>fl/fl</sup></italic> mice (<xref ref-type="bibr" rid="bib18">Djukic et al., 2007</xref>) (The Jackson Laboratory, stock no: 026826) by Dr. Dwight Bergles (Johns Hopkins School of Medicine), and <italic>ROSA26<sup>mEGFP</sup></italic> mice (<xref ref-type="bibr" rid="bib65">Muzumdar et al., 2007</xref>) (The Jackson Laboratory, stock no: 007576) by Dr. David Linden (Johns Hopkins School of Medicine). <italic>ROSA26<sup>eGFP-DTA</sup></italic> mice were obtained from The Jackson Laboratory (stock no: 006331).</p></sec><sec id="s4-2"><title>Tamoxifen injections</title><p>At postnatal day 30, C57Bl/6J, <italic>Fabp7-CreER2;ROSA26<sup>mEGFP</sup>, Fabp7-CreER2;ROSA26<sup>eGFP-DTA</sup></italic>, or <italic>Fabp7-CreER2;Kcnj10<sup>fl/fl</sup></italic> mice were injected subcutaneously with either vehicle corn oil (Sigma) or tamoxifen (180 mg/kg body weight) dissolved in corn oil for five consecutive days. All analyses were performed at 5 or 14 days after the last injection.</p></sec><sec id="s4-3"><title>Quantitative PCR</title><p>RNA was isolated from dissected SCGs or cardiac tissue using Absolutely RNA Nanoprep Kit (Agilent) or Trizol-chloroform extraction. cDNA was prepared using Superscript IV First Strand Synthesis System. Real-time qPCR analysis was performed using Maxima SYBER Green/Rox Q-PCR Master Mix (Thermo Fisher) and gene-specific primers for SCG tissues or TaqMan probes for adrenergic receptors in heart tissue, in a 7300 Real time PCR System (Applied Biosystems). Each sample was analyzed in triplicate reactions. Fold change was calculated using the <inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msup><mml:mn>2</mml:mn><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>C</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:mstyle></mml:math></inline-formula> method, normalizing to 18S transcript.</p></sec><sec id="s4-4"><title>Single-molecule fluorescence in situ hybridization</title><p>SCGs were dissected from P48 mice, cryoprotected in 30% sucrose in PBS for 1 hr and embedded in OCT and frozen at –80°C. Ganglia were cryosectioned at 14 µm and kept at –80°C until smFISH was performed. Target mRNA was probed using RNAscope Multiplex Fluorescent Reagent Kit v2 Assay. Tissues were incubated in fresh 4% paraformaldehyde for 5 min, washed twice in 1× PBS, and dehydrated with increasing concentrations of ethanol. Subsequently, tissues were treated with hydrogen peroxide for 10 min and protease treatment for 15 min. RNAscope assays were performed following the manufacturer’s instructions. Tissues were mounted with Prolong Anti-fade Mounting Media and imaged using a Zeiss LSM 800 confocal microscope.</p></sec><sec id="s4-5"><title>Immunohistochemical analyses</title><p>SCGs were harvested and incubated in 4% paraformaldehyde for 4 hr at room temperature, cryoprotected in 30% sucrose in 1× PBS for 3 days, embedded in OCT (Sakura Finetek) and stored at –80°C. Ganglia were cryosectioned at 12–30 μm sections for immunohistochemistry. For paraffin embedding, SCGs were fixed in Bouin’s solution for 1 hr at room temperature, left in 70% ethanol overnight at room temperature, followed by consecutive washes in 70, 80, 95, and 100% ethanol, and xylene. Tissues were embedded in paraffin wax and sectioned at 6 µm using a microtome, and rehydrated using a series of xylene and ethanol washes at room temperature. Tissue sections were permeabilized in 0.1% Triton X-100 in 1× PBS at room temperature 3× for 5 min each, followed by incubation in 10 mM sodium citrate buffer (pH 6) at 95°C for 10 min. Tissues were blocked in 5% goat serum/3% bovine serum albumin in 0.1% or 0.3% Triton X-100 in 1× PBS (blocking solution) for 1 hr at room temperature. Primary antibodies used were mouse anti-BLBP (1:500), rabbit anti-BLBP (1:200), mouse anti-TH (1:300), rabbit anti-TH (1:300), rabbit anti-TrkA (1:200), rabbit anti-IBA1 (1:200), rabbit anti-pS6 (1:200), rabbit anti-p4E-BP1 (1:200), rabbit anti-c-Fos (1:1000), goat anti-Sox10 (1:50), or rabbit anti-Kir4.1 (1:100) with incubations performed overnight at 4°C. Slides were washed in blocking solution and then incubated in Alexa-488 ,-546, or-647 conjugated anti-rabbit or anti-mouse secondary antibodies (1:200 dilution) and DAPI (1:1000) in blocking buffer. Tissues were then mounted in Aqueous Mounting Medium and imaged at 1 µm optical slices using a Zeiss LSM 700 or LSM 800 confocal microscope. Maximum intensity projections and maximum intensity 3D projections were generated using ImageJ.</p><p>For Sox-2 immunostaining, SCGs were embedded in 3% agarose (Sigma) and sectioned at 100-µm-thick sections using a vibratome. Tissues were permeabilized/blocked in 10% goat serum/3% tween in 1× PBS for 2 hr at room temperature, incubated with rabbit anti-Sox2 (1:500) and mouse anti-TH (1:300) antibodies in blocking solution for 2 days at 4°C, followed by Alexa-546 or -647 conjugated anti-rabbit or anti-mouse secondary antibodies (1:400 dilution) and DAPI (1:1000). Maximum intensity 3D projections were generated using ImageJ.</p><p>Binary images of Sox2<sup>+</sup> cells were generated using Fourier Bandpass Filter plug-in on ImageJ to first reduce edge artifacts, and then adjusting the threshold to the maximum fluorescence intensity of 255 nm. Particles of sizes between 3 and 50 μm were quantified using the ‘Analyze Particle’ plug-in on ImageJ.</p><p>For TH DAB immunohistochemistry, paraffin sections (6 μm) of SCGs were prepared as described above. After tissues were rehydrated, peroxidase quenching was done by incubation in a tris buffer solution (TBS) containing 3% hydrogen peroxide/5% methanol for 15 min at room temperature. Tissues were then permeabilized/blocked in 10% donkey serum/1% glycine/2% bovine serum albumin/0.4% Triton X-100 in 1× TBS for 2 hr at room temperature, incubated with rabbit anti-TH (1:200) in blocking solution overnight at 4°C. Slides were washed three times with TBS, incubated with rabbit anti-HRP in blocking solution for 1 hr at room temperature, washed with TBS before being incubated with SIGMAFAST 3,3'-diaminobenzidine for 10 min. Tissues were washed once with TBS and counterstained with hematoxylin for 1 min prior to dehydrating in increasing concentrations of ethanol and xylene. Tissues were mounted with Permount Mounting Media. Glial nuclei associated with TH-positive neurons in SCGs were counted using ImageJ.</p></sec><sec id="s4-6"><title>iDISCO and wholemount immunostaining</title><p>iDISCO-based tissue clearing for wholemount immunostaining of organs from P48 mice was performed as previously described (<xref ref-type="bibr" rid="bib71">Renier et al., 2014</xref>). Briefly, hearts were fixed in 4% PFA/PBS, then dehydrated by methanol series (20–80%) and incubated overnight in 66% dichloromethane (DCM)/33% methanol. Samples were then bleached with 5% H<sub>2</sub>O<sub>2</sub> in methanol at 4°C overnight, then re-hydrated and permeabilized first with 0.2% Triton X-100 followed by overnight permeabilization with 0.16% Triton X-100/20% DMSO/0.3 M glycine in PBS. Samples were incubated in blocking solution (0.17% Triton X-100/10% DMSO/6% Normal Goat Serum in PBS) for 8 hr, and then incubated with rabbit anti-TH (1:400) in 0.2% Tween-20/0.001% heparin/5% DMSO/3% Normal Goat Serum in PBS at 37°C for 96 hr. Samples were then washed with 0.2% Tween-20/0.001% heparin in PBS and incubated with anti-rabbit Alexa-546 secondary antibody (1:400) in 0.2% Tween-20/0.001% heparin/3% Normal Goat Serum in PBS. After 96 hr, organs were extensively washed with 0.2% Tween-20/0.001% heparin in PBS and dehydrated in methanol. Samples were cleared by successive washes in 66% DCM/33% methanol, 100% DCM, and 100% dibenzyl ether. Organs were imaged on a lightsheet microscope (LaVision BioTec Ultra Microscope II). Imaris was used for 3D manipulations. Total axon lengths and number of branch points were quantified using Imaris Filament Tracer and normalized to total organ volume.</p></sec><sec id="s4-7"><title>Soma size</title><p>SCG tissue sections were labeled with hematoxylin and eosin. Cells with characteristic neuronal morphology and visible nucleoli were identified, soma were traced and areas (µm<sup>2</sup>) quantified using ImageJ (Fiji).</p></sec><sec id="s4-8"><title>Neuronal cell counts</title><p>Neuronal counts were performed as previously described (<xref ref-type="bibr" rid="bib76">Scott-Solomon and Kuruvilla, 2020</xref>). In brief, torsos of P39-48 mice were fixed in 4% PFA/PBS overnight and cryoprotected in 30% sucrose/PBS for 48 hr. Torsos were then mounted in OCT and serially sectioned (12 μm). Next, every fifth section was stained with solution containing 0.5% cresyl violet (Nissl). Cells in both SCGs with characteristic neuronal morphology and visible nucleoli were counted using ImageJ.</p></sec><sec id="s4-9"><title>TUNEL</title><p>Apoptotic cells were identified in every fifth section of ganglia. Tissues were first incubated with primary and secondary antibodies as described above, followed by detection of cell death using TUNEL staining (Roche) according to the manufacturer’s protocol. Cells that were double positive for DAPI and TUNEL were counted as dying cells. To quantify neuronal or glial apoptosis, TUNEL labeling was done together with TrkA or Sox10 immunostaining as described above. TUNEL<sup>+</sup>; TrkA<sup>+</sup> and TUNEL<sup>+</sup>; Sox10<sup>+</sup> cells were expressed as percentages of the total number of TrkA<sup>+</sup> and Sox 10<sup>+</sup> cells, respectively.</p></sec><sec id="s4-10"><title>EdU labeling</title><p>Tamoxifen- or corn oil-injected adult mice were injected intraperitoneally with EdU (Invitrogen, 100 µg/ml in 3:1 PBS/DMSO) for five consecutive days before harvesting at 5 days post-tamoxifen injections. SCG tissue sections (12 μm) were processed for 30 min at room temperature in EdU reaction cocktail (Thermo Fisher EdU kit C10337; Click-iT buffer, Buffer additive, CuSO<sub>4</sub> solution, and Alexa Fluor 488). Sections were then washed in PBS +0.1% Triton X-100 and mounted with Fluoromount + DAPI. Images were collected using a Zeiss LSM 700 confocal microscope. The total number of cells that incorporated EdU in each section was counted and summed for an entire SCG.</p></sec><sec id="s4-11"><title>Norepinephrine ELISA</title><p>Blood samples drawn from anesthetized mice were centrifuged for 15 min, 3000 rpm in 0.5 M EDTA-coated tubes at 4°C. NE levels in plasma (300 μl) was assessed using a ELISA kit (Abnova) according to the manufacturer’s protocol.</p></sec><sec id="s4-12"><title>Pupil analyses</title><p>Pupil size measurements were performed as reported previously (<xref ref-type="bibr" rid="bib43">Keenan et al., 2016</xref>). Briefly, all mice were dark-adapted and housed in single cages for 2 days and analyzed in the evenings. For all experiments, mice were unanesthetized and restrained by hand. To mitigate stress, which can affect pupil size, researchers handled mice for several days prior to the measurements. Videos of the eye were recorded for 5–10 s in the dark using a Sony Handycam (DCR-HC96) mounted on a tripod at a fixed distance from the mouse. Manual focus was maintained on the camera to ensure that only one focal plane existed for each mouse. Pupil size was recorded under dim red light and the endogenous infrared light source of the camera to capture the basal pupil size.</p><p>To examine parasympathetic activity, mice were dark-adapted for 2 days. Unanesthetized mice were restrained by hand. Pupil size was recorded first for 5–10 s in the dark followed by a 30 s exposure to a light step stimulus. The light stimulus was provided by 10 W or 14 W LED bulbs (Sunlite A19/or Sunlite 80599-SU LED A19 Super Bright Light Bulb, Daylight). Light intensity was measured using a light meter (EXTECH Foot Candle/Lux Light Meter, 401025) at the surface on which the mouse was held. Light intensity was adjusted by a combination of altering the distance of the light bulb from the mouse and/or applying neutral density filters (Roscolux). The light meter is unreliable at detecting light intensities below 1 lux, so one neutral density filter cutting the light intensity by 12.5% was applied to the bulb to estimate 1-log unit decreases in illumination below 1 lux. Light intensities above 500 lux required the use of multiple light bulbs.</p></sec><sec id="s4-13"><title>Electrocardiograms</title><p>ECG recordings were performed on adult mice as previously described (<xref ref-type="bibr" rid="bib78">Ståhlberg et al., 2019</xref>). Briefly, adult mice (P39-48) were anesthetized with 4% isoflurane, intubated, and placed on ventilator support (settings 1.2 ml/g/min at 80 breaths/min). The animal’s dorsum was shaved, scrubbed with betadine and alcohol, and draped with a sterile barrier with the surgery site exposed. A small 0.5 cm midline incision was performed and ECG leads were implanted subcutaneously and sutured over the trapezius muscle on both sides. Body temperature was maintained at 37°C. Immediately following implantation, the wound was closed with a 3-0 silk suture. Anesthesia was turned off and the animal was monitored for spontaneous breathing and was given a subcutaneous buprenorphine injection (0.01–0.05 mg/kg buprenorphine, IM) to alleviate pain. ECGs were subsequently recorded continuously in conscious animals for approximately 7 days for each mouse using the Powerlab data acquisition device and LabChart 8 software (ADInstruments). Mice were kept at a stable temperature with regular 12 hr light/dark cycle. To exclude the effects of pain and anesthesia, continuous ECG recordings between day 4 and 7 post-lead implantation were only included in the analysis of mean heart rates. HRV was analyzed using LabChart 8 and at 10–12 hr intervals as previously described (<xref ref-type="bibr" rid="bib80">Thireau et al., 2008</xref>).</p><p>To assess effects of tamoxifen alone, adult (P39-48) C57Bl/6J or <italic>ROSA26<sup>eGFP-DTA</sup></italic> mice that did not express Cre mice were injected with corn oil or tamoxifen (subcutaneous injections, 180 mg/kg body weight for five consecutive days) and ECGs recorded as described above.</p></sec><sec id="s4-14"><title>6-OHDA injections</title><p>For chemical ablation of sympathetic nerves, <italic>Fabp7-CreER2;ROSA26<sup>eGFP-DTA</sup></italic> mice were first injected with corn oil or tamoxifen. After 18–20 days, control and BLBP:iDTA mice received two intraperitoneal injections, 3 days apart, of 6-OHDA (150 mg/kg) dissolved in 0.1% ascorbic acid. ECGs were subsequently recorded continuously in conscious animals for approximately 4 days for each mouse as described above.</p></sec><sec id="s4-15"><title>Quantification and statistical analyses</title><p>Sample sizes in this study were calculated using power analyses using RStudio statistical software. For practical reasons, analyses of innervation, cell death assays, proliferation assays, soma size measurements, and NE ELISA’s were performed in a semi-blinded manner. The experimenter was aware of the genotypes but performed each immunostaining and measurements without knowing the genotypes. All physiological experiments (pupil dilation and HRV) were performed in a blinded manner; the experimenter was only aware of the ear tag numbers. All <italic>t</italic>-tests were performed assuming Gaussian distribution, two-tailed, unpaired, and a confidence interval of 95%. One-way or two-way ANOVA with Bonferroni’s correction were performed when more than two groups were compared. All error bars represent the standard error of the mean (SEM).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Methodology</p></fn><fn fn-type="con" id="con3"><p>Methodology</p></fn><fn fn-type="con" id="con4"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Methodology</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Resources</p></fn><fn fn-type="con" id="con8"><p>Resources, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Resources, Funding acquisition, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Funding acquisition, Writing - original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All procedures relating to animal care and treatment conformed to The Johns Hopkins University Animal Care and Use Committee (ACUC, protocol#MO19A488) and NIH guidelines.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-74295-transrepform1-v3.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript (Results, Materials and Methods, and Figure Legends).</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank all members of the Kuruvilla, Zhao, and Hattar labs for helpful comments on the project. This work was supported by NIH R01 awards, NS073751 and NS107342, to RK, DC016065 and EY027202 to HZ, NIMH intramural research funds (ZIAMH002964) to SH, a NSF GRFP (DGE-1746891) award to AM, and NIH Training grant T32GM007231 to the JHU CMDB graduate program for AM and EB.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>NJ</given-names></name><name><surname>Lyons</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Glia as architects of central nervous system formation and function</article-title><source>Science</source><volume>362</volume><fpage>181</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1126/science.aat0473</pub-id><pub-id pub-id-type="pmid">30309945</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ameroso</surname><given-names>D</given-names></name><name><surname>Meng</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Felsted</surname><given-names>J</given-names></name><name><surname>Dulla</surname><given-names>CG</given-names></name><name><surname>Rios</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Astrocytic BDNF signaling within the ventromedial hypothalamus regulates energy homeostasis</article-title><source>Nature Metabolism</source><volume>4</volume><fpage>627</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1038/s42255-022-00566-0</pub-id><pub-id pub-id-type="pmid">35501599</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angeletti</surname><given-names>PU</given-names></name><name><surname>Levi-Montalcini</surname><given-names>R</given-names></name><name><surname>Caramia</surname><given-names>F</given-names></name></person-group><year iso-8601-date="1971">1971</year><article-title>Analysis of the effects of the antiserum to the nerve growth factor in adult mice</article-title><source>Brain Research</source><volume>27</volume><fpage>343</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(71)90259-9</pub-id><pub-id pub-id-type="pmid">5552175</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avraham</surname><given-names>O.</given-names></name><name><surname>Deng</surname><given-names>PY</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Kuruvilla</surname><given-names>R</given-names></name><name><surname>Semenkovich</surname><given-names>CF</given-names></name><name><surname>Klyachko</surname><given-names>VA</given-names></name><name><surname>Cavalli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Satellite glial cells promote regenerative growth in sensory neurons</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>4891</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-18642-y</pub-id><pub-id pub-id-type="pmid">32994417</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avraham</surname><given-names>O</given-names></name><name><surname>Feng</surname><given-names>R</given-names></name><name><surname>Ewan</surname><given-names>EE</given-names></name><name><surname>Rustenhoven</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Cavalli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Profiling sensory neuron microenvironment after peripheral and central axon injury reveals key pathways for neural repair</article-title><source>eLife</source><volume>10</volume><elocation-id>e68457</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.68457</pub-id><pub-id pub-id-type="pmid">34586065</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avraham</surname><given-names>O</given-names></name><name><surname>Chamessian</surname><given-names>A</given-names></name><name><surname>Feng</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Halevi</surname><given-names>AE</given-names></name><name><surname>Moore</surname><given-names>AM</given-names></name><name><surname>Gereau</surname><given-names>RW</given-names></name><name><surname>Cavalli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Profiling the molecular signature of satellite glial cells at the single cell level reveals high similarities between rodents and humans</article-title><source>Pain</source><volume>1</volume><elocation-id>2628</elocation-id><pub-id pub-id-type="doi">10.1097/j.pain.0000000000002628</pub-id><pub-id pub-id-type="pmid">35503034</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badimon</surname><given-names>A</given-names></name><name><surname>Strasburger</surname><given-names>HJ</given-names></name><name><surname>Ayata</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Nair</surname><given-names>A</given-names></name><name><surname>Ikegami</surname><given-names>A</given-names></name><name><surname>Hwang</surname><given-names>P</given-names></name><name><surname>Chan</surname><given-names>AT</given-names></name><name><surname>Graves</surname><given-names>SM</given-names></name><name><surname>Uweru</surname><given-names>JO</given-names></name><name><surname>Ledderose</surname><given-names>C</given-names></name><name><surname>Kutlu</surname><given-names>MG</given-names></name><name><surname>Wheeler</surname><given-names>MA</given-names></name><name><surname>Kahan</surname><given-names>A</given-names></name><name><surname>Ishikawa</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y-C</given-names></name><name><surname>Loh</surname><given-names>Y-HE</given-names></name><name><surname>Jiang</surname><given-names>JX</given-names></name><name><surname>Surmeier</surname><given-names>DJ</given-names></name><name><surname>Robson</surname><given-names>SC</given-names></name><name><surname>Junger</surname><given-names>WG</given-names></name><name><surname>Sebra</surname><given-names>R</given-names></name><name><surname>Calipari</surname><given-names>ES</given-names></name><name><surname>Kenny</surname><given-names>PJ</given-names></name><name><surname>Eyo</surname><given-names>UB</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name><name><surname>Quintana</surname><given-names>FJ</given-names></name><name><surname>Wake</surname><given-names>H</given-names></name><name><surname>Gradinaru</surname><given-names>V</given-names></name><name><surname>Schaefer</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Negative feedback control of neuronal activity by microglia</article-title><source>Nature</source><volume>586</volume><fpage>417</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2777-8</pub-id><pub-id pub-id-type="pmid">32999463</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batiuk</surname><given-names>MY</given-names></name><name><surname>Martirosyan</surname><given-names>A</given-names></name><name><surname>Wahis</surname><given-names>J</given-names></name><name><surname>de Vin</surname><given-names>F</given-names></name><name><surname>Marneffe</surname><given-names>C</given-names></name><name><surname>Kusserow</surname><given-names>C</given-names></name><name><surname>Koeppen</surname><given-names>J</given-names></name><name><surname>Viana</surname><given-names>JF</given-names></name><name><surname>Oliveira</surname><given-names>JF</given-names></name><name><surname>Voet</surname><given-names>T</given-names></name><name><surname>Ponting</surname><given-names>CP</given-names></name><name><surname>Belgard</surname><given-names>TG</given-names></name><name><surname>Holt</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Identification of region-specific astrocyte subtypes at single cell resolution</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>1220</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-14198-8</pub-id><pub-id pub-id-type="pmid">32139688</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boehm</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>ATP stimulates sympathetic transmitter release via presynaptic P2X purinoceptors</article-title><source>The Journal of Neuroscience</source><volume>19</volume><fpage>737</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-02-00737.1999</pub-id><pub-id pub-id-type="pmid">9880594</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boison</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>JF</given-names></name><name><surname>Fredholm</surname><given-names>BB</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Adenosine signaling and function in glial cells</article-title><source>Cell Death and Differentiation</source><volume>17</volume><fpage>1071</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1038/cdd.2009.131</pub-id><pub-id pub-id-type="pmid">19763139</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borden</surname><given-names>P</given-names></name><name><surname>Houtz</surname><given-names>J</given-names></name><name><surname>Leach</surname><given-names>SD</given-names></name><name><surname>Kuruvilla</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sympathetic innervation during development is necessary for pancreatic islet architecture and functional maturation</article-title><source>Cell Reports</source><volume>4</volume><fpage>287</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.06.019</pub-id><pub-id pub-id-type="pmid">23850289</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Britsch</surname><given-names>S</given-names></name><name><surname>Goerich</surname><given-names>DE</given-names></name><name><surname>Riethmacher</surname><given-names>D</given-names></name><name><surname>Peirano</surname><given-names>RI</given-names></name><name><surname>Rossner</surname><given-names>M</given-names></name><name><surname>Nave</surname><given-names>KA</given-names></name><name><surname>Birchmeier</surname><given-names>C</given-names></name><name><surname>Wegner</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The transcription factor sox10 is a key regulator of peripheral glial development</article-title><source>Genes &amp; Development</source><volume>15</volume><fpage>66</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1101/gad.186601</pub-id><pub-id pub-id-type="pmid">11156606</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Causing</surname><given-names>CG</given-names></name><name><surname>Gloster</surname><given-names>A</given-names></name><name><surname>Aloyz</surname><given-names>R</given-names></name><name><surname>Bamji</surname><given-names>SX</given-names></name><name><surname>Chang</surname><given-names>E</given-names></name><name><surname>Fawcett</surname><given-names>J</given-names></name><name><surname>Kuchel</surname><given-names>G</given-names></name><name><surname>Miller</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Synaptic innervation density is regulated by neuron-derived BDNF</article-title><source>Neuron</source><volume>18</volume><fpage>257</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80266-4</pub-id><pub-id pub-id-type="pmid">9052796</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceasrine</surname><given-names>AM</given-names></name><name><surname>Lin</surname><given-names>EE</given-names></name><name><surname>Lumelsky</surname><given-names>DN</given-names></name><name><surname>Iyer</surname><given-names>R</given-names></name><name><surname>Kuruvilla</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Adrb2 controls glucose homeostasis by developmental regulation of pancreatic islet vasculature</article-title><source>eLife</source><volume>7</volume><elocation-id>e39689</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.39689</pub-id><pub-id pub-id-type="pmid">30303066</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cserép</surname><given-names>C</given-names></name><name><surname>Pósfai</surname><given-names>B</given-names></name><name><surname>Lénárt</surname><given-names>N</given-names></name><name><surname>Fekete</surname><given-names>R</given-names></name><name><surname>László</surname><given-names>ZI</given-names></name><name><surname>Lele</surname><given-names>Z</given-names></name><name><surname>Orsolits</surname><given-names>B</given-names></name><name><surname>Molnár</surname><given-names>G</given-names></name><name><surname>Heindl</surname><given-names>S</given-names></name><name><surname>Schwarcz</surname><given-names>AD</given-names></name><name><surname>Ujvári</surname><given-names>K</given-names></name><name><surname>Környei</surname><given-names>Z</given-names></name><name><surname>Tóth</surname><given-names>K</given-names></name><name><surname>Szabadits</surname><given-names>E</given-names></name><name><surname>Sperlágh</surname><given-names>B</given-names></name><name><surname>Baranyi</surname><given-names>M</given-names></name><name><surname>Csiba</surname><given-names>L</given-names></name><name><surname>Hortobágyi</surname><given-names>T</given-names></name><name><surname>Maglóczky</surname><given-names>Z</given-names></name><name><surname>Martinecz</surname><given-names>B</given-names></name><name><surname>Szabó</surname><given-names>G</given-names></name><name><surname>Erdélyi</surname><given-names>F</given-names></name><name><surname>Szipőcs</surname><given-names>R</given-names></name><name><surname>Tamkun</surname><given-names>MM</given-names></name><name><surname>Gesierich</surname><given-names>B</given-names></name><name><surname>Duering</surname><given-names>M</given-names></name><name><surname>Katona</surname><given-names>I</given-names></name><name><surname>Liesz</surname><given-names>A</given-names></name><name><surname>Tamás</surname><given-names>G</given-names></name><name><surname>Dénes</surname><given-names>Á</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Microglia monitor and protect neuronal function through specialized somatic purinergic junctions</article-title><source>Science</source><volume>367</volume><fpage>528</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1126/science.aax6752</pub-id><pub-id pub-id-type="pmid">31831638</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Ni</surname><given-names>Z</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>G</given-names></name><name><surname>Foncelle</surname><given-names>A</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Sang</surname><given-names>K</given-names></name><name><surname>Tang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Berry</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Astroglial kir4.1 in the lateral habenula drives neuronal bursts in depression</article-title><source>Nature</source><volume>554</volume><fpage>323</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1038/nature25752</pub-id><pub-id pub-id-type="pmid">29446379</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lucia</surname><given-names>C</given-names></name><name><surname>Eguchi</surname><given-names>A</given-names></name><name><surname>Koch</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>New insights in cardiac β-adrenergic signaling during heart failure and aging</article-title><source>Frontiers in Pharmacology</source><volume>9</volume><elocation-id>904</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2018.00904</pub-id><pub-id pub-id-type="pmid">30147654</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djukic</surname><given-names>B</given-names></name><name><surname>Casper</surname><given-names>KB</given-names></name><name><surname>Philpot</surname><given-names>BD</given-names></name><name><surname>Chin</surname><given-names>LS</given-names></name><name><surname>McCarthy</surname><given-names>KD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Conditional knock-out of kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>11354</fpage><lpage>11365</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0723-07.2007</pub-id><pub-id pub-id-type="pmid">17942730</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebrahimi</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Sharifi</surname><given-names>K</given-names></name><name><surname>Kida</surname><given-names>H</given-names></name><name><surname>Kagawa</surname><given-names>Y</given-names></name><name><surname>Yasumoto</surname><given-names>Y</given-names></name><name><surname>Islam</surname><given-names>A</given-names></name><name><surname>Miyazaki</surname><given-names>H</given-names></name><name><surname>Shimamoto</surname><given-names>C</given-names></name><name><surname>Maekawa</surname><given-names>M</given-names></name><name><surname>Mitsushima</surname><given-names>D</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Owada</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Astrocyte-expressed FABP7 regulates dendritic morphology and excitatory synaptic function of cortical neurons</article-title><source>Glia</source><volume>64</volume><fpage>48</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1002/glia.22902</pub-id><pub-id pub-id-type="pmid">26296243</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elfvin</surname><given-names>LG</given-names></name><name><surname>Forsman</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>The ultrastructure of junctions between satellite cells in mammalian sympathetic ganglia as revealed by freeze-etching</article-title><source>Journal of Ultrastructure Research</source><volume>63</volume><fpage>261</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/s0022-5320(78)80051-3</pub-id><pub-id pub-id-type="pmid">682227</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enes</surname><given-names>J</given-names></name><name><surname>Haburčák</surname><given-names>M</given-names></name><name><surname>Sona</surname><given-names>S</given-names></name><name><surname>Gerard</surname><given-names>N</given-names></name><name><surname>Mitchell</surname><given-names>AC</given-names></name><name><surname>Fu</surname><given-names>W</given-names></name><name><surname>Birren</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Satellite glial cells modulate cholinergic transmission between sympathetic neurons</article-title><source>PLOS ONE</source><volume>15</volume><elocation-id>e0218643</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0218643</pub-id><pub-id pub-id-type="pmid">32017764</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eschenhagen</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Beta-adrenergic signaling in heart failure-adapt or die</article-title><source>Nature Medicine</source><volume>14</volume><fpage>485</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1038/nm0508-485</pub-id><pub-id pub-id-type="pmid">18463653</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>RJ</given-names></name><name><surname>Derkach</surname><given-names>V</given-names></name><name><surname>Surprenant</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>ATP mediates fast synaptic transmission in mammalian neurons</article-title><source>Nature</source><volume>357</volume><fpage>503</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1038/357503a0</pub-id><pub-id pub-id-type="pmid">1351659</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagan</surname><given-names>AM</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Landis</surname><given-names>S</given-names></name><name><surname>Smeyne</surname><given-names>RJ</given-names></name><name><surname>Silos-Santiago</surname><given-names>I</given-names></name><name><surname>Barbacid</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>TrkA, but not trkc, receptors are essential for survival of sympathetic neurons in vivo</article-title><source>The Journal of Neuroscience</source><volume>16</volume><fpage>6208</fpage><lpage>6218</lpage><pub-id pub-id-type="pmid">8815902</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman-Goriachnik</surname><given-names>R</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Hanani</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cholinergic responses of satellite glial cells in the superior cervical ganglia</article-title><source>Neuroscience Letters</source><volume>671</volume><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2018.01.051</pub-id><pub-id pub-id-type="pmid">29391220</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman-Goriachnik</surname><given-names>R</given-names></name><name><surname>Hanani</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The effects of sympathetic nerve damage on satellite glial cells in the mouse superior cervical ganglion</article-title><source>Autonomic Neuroscience</source><volume>221</volume><elocation-id>102584</elocation-id><pub-id pub-id-type="doi">10.1016/j.autneu.2019.102584</pub-id><pub-id pub-id-type="pmid">31494528</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>L</given-names></name><name><surname>Hatten</surname><given-names>ME</given-names></name><name><surname>Heintz</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Brain lipid-binding protein (BLBP): a novel signaling system in the developing mammalian CNS</article-title><source>Neuron</source><volume>12</volume><fpage>895</fpage><lpage>908</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(94)90341-7</pub-id><pub-id pub-id-type="pmid">8161459</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsman</surname><given-names>CA</given-names></name><name><surname>Elfvin</surname><given-names>LG</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Cytochemical localization of 5’-nucleotidase in guinea-pig sympathetic ganglia</article-title><source>Journal of Neurocytology</source><volume>13</volume><fpage>339</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1007/BF01148327</pub-id><pub-id pub-id-type="pmid">6090595</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabella</surname><given-names>G</given-names></name><name><surname>Trigg</surname><given-names>P</given-names></name><name><surname>McPhail</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Quantitative cytology of ganglion neurons and satellite glial cells in the superior cervical ganglion of the sheep: relationship with ganglion neuron size</article-title><source>Journal of Neurocytology</source><volume>17</volume><fpage>753</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1007/BF01216704</pub-id><pub-id pub-id-type="pmid">3230395</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gervasi</surname><given-names>NM</given-names></name><name><surname>Scott</surname><given-names>SS</given-names></name><name><surname>Aschrafi</surname><given-names>A</given-names></name><name><surname>Gale</surname><given-names>J</given-names></name><name><surname>Vohra</surname><given-names>SN</given-names></name><name><surname>MacGibeny</surname><given-names>MA</given-names></name><name><surname>Kar</surname><given-names>AN</given-names></name><name><surname>Gioio</surname><given-names>AE</given-names></name><name><surname>Kaplan</surname><given-names>BB</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The local expression and trafficking of tyrosine hydroxylase mrna in the axons of sympathetic neurons</article-title><source>RNA</source><volume>22</volume><fpage>883</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1261/rna.053272.115</pub-id><pub-id pub-id-type="pmid">27095027</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glebova</surname><given-names>NO</given-names></name><name><surname>Ginty</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Growth and survival signals controlling sympathetic nervous system development</article-title><source>Annual Review of Neuroscience</source><volume>28</volume><fpage>191</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.28.061604.135659</pub-id><pub-id pub-id-type="pmid">16022594</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>DS</given-names></name><name><surname>Robertson</surname><given-names>D</given-names></name><name><surname>Esler</surname><given-names>M</given-names></name><name><surname>Straus</surname><given-names>SE</given-names></name><name><surname>Eisenhofer</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Dysautonomias: clinical disorders of the autonomic nervous system</article-title><source>Annals of Internal Medicine</source><volume>137</volume><fpage>753</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-137-9-200211050-00011</pub-id><pub-id pub-id-type="pmid">12416949</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2013">2013</year><chapter-title>Differential responses of components of the autonomic nervous system</chapter-title><person-group person-group-type="editor"><name><surname>Goldstein</surname><given-names>DS</given-names></name></person-group><source>Handbook of Clinical Neurology</source><publisher-name>Elsevier</publisher-name><fpage>13</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/B978-0-444-53491-0.00002-X</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>AK</given-names></name><name><surname>Landis</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Division and migration of satellite glia in the embryonic rat superior cervical ganglion</article-title><source>Journal of Neurocytology</source><volume>21</volume><fpage>635</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1007/BF01191725</pub-id><pub-id pub-id-type="pmid">1403009</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanani</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Satellite glial cells in sympathetic and parasympathetic ganglia: in search of function</article-title><source>Brain Research Reviews</source><volume>64</volume><fpage>304</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1016/j.brainresrev.2010.04.009</pub-id><pub-id pub-id-type="pmid">20441777</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanani</surname><given-names>M</given-names></name><name><surname>Spray</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Emerging importance of satellite glia in nervous system function and dysfunction</article-title><source>Nature Reviews. Neuroscience</source><volume>21</volume><fpage>485</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1038/s41583-020-0333-z</pub-id><pub-id pub-id-type="pmid">32699292</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanani</surname><given-names>M</given-names></name><name><surname>Verkhratsky</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Satellite glial cells and astrocytes, a comparative review</article-title><source>Neurochemical Research</source><volume>46</volume><fpage>2525</fpage><lpage>2537</lpage><pub-id pub-id-type="doi">10.1007/s11064-021-03255-8</pub-id><pub-id pub-id-type="pmid">33523395</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasan</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Autonomic cardiac innervation: development and adult plasticity</article-title><source>Organogenesis</source><volume>9</volume><fpage>176</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.4161/org.24892</pub-id><pub-id pub-id-type="pmid">23872607</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haydon</surname><given-names>PG</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>GLIA: listening and talking to the synapse</article-title><source>Nature Reviews. Neuroscience</source><volume>2</volume><fpage>185</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1038/35058528</pub-id><pub-id pub-id-type="pmid">11256079</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>TY</given-names></name><name><surname>Cherkas</surname><given-names>PS</given-names></name><name><surname>Rosenthal</surname><given-names>DW</given-names></name><name><surname>Hanani</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Dye coupling among satellite glial cells in mammalian dorsal root ganglia</article-title><source>Brain Research</source><volume>1036</volume><fpage>42</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2004.12.021</pub-id><pub-id pub-id-type="pmid">15725400</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanova</surname><given-names>A</given-names></name><name><surname>Signore</surname><given-names>M</given-names></name><name><surname>Caro</surname><given-names>N</given-names></name><name><surname>Greene</surname><given-names>NDE</given-names></name><name><surname>Copp</surname><given-names>AJ</given-names></name><name><surname>Martinez-Barbera</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>In vivo genetic ablation by cre-mediated expression of diphtheria toxin fragment A</article-title><source>Genesis</source><volume>43</volume><fpage>129</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1002/gene.20162</pub-id><pub-id pub-id-type="pmid">16267821</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jager</surname><given-names>SE</given-names></name><name><surname>Pallesen</surname><given-names>LT</given-names></name><name><surname>Richner</surname><given-names>M</given-names></name><name><surname>Harley</surname><given-names>P</given-names></name><name><surname>Hore</surname><given-names>Z</given-names></name><name><surname>McMahon</surname><given-names>S</given-names></name><name><surname>Denk</surname><given-names>F</given-names></name><name><surname>Vaegter</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Changes in the transcriptional fingerprint of satellite glial cells following peripheral nerve injury</article-title><source>Glia</source><volume>68</volume><fpage>1375</fpage><lpage>1395</lpage><pub-id pub-id-type="doi">10.1002/glia.23785</pub-id><pub-id pub-id-type="pmid">32045043</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keenan</surname><given-names>WT</given-names></name><name><surname>Rupp</surname><given-names>AC</given-names></name><name><surname>Ross</surname><given-names>RA</given-names></name><name><surname>Somasundaram</surname><given-names>P</given-names></name><name><surname>Hiriyanna</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Badea</surname><given-names>TC</given-names></name><name><surname>Robinson</surname><given-names>PR</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name><name><surname>Hattar</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A visual circuit uses complementary mechanisms to support transient and sustained pupil constriction</article-title><source>eLife</source><volume>5</volume><elocation-id>e15392</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.15392</pub-id><pub-id pub-id-type="pmid">27669145</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelley</surname><given-names>KW</given-names></name><name><surname>Ben Haim</surname><given-names>L</given-names></name><name><surname>Schirmer</surname><given-names>L</given-names></name><name><surname>Tyzack</surname><given-names>GE</given-names></name><name><surname>Tolman</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>JG</given-names></name><name><surname>Tsai</surname><given-names>H-H</given-names></name><name><surname>Chang</surname><given-names>SM</given-names></name><name><surname>Molofsky</surname><given-names>AV</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Patani</surname><given-names>R</given-names></name><name><surname>Lakatos</surname><given-names>A</given-names></name><name><surname>Ullian</surname><given-names>EM</given-names></name><name><surname>Rowitch</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Kir4.1-dependent astrocyte-fast motor neuron interactions are required for peak strength</article-title><source>Neuron</source><volume>98</volume><fpage>306</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.03.010</pub-id><pub-id pub-id-type="pmid">29606582</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Anderson</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Gong</surname><given-names>C</given-names></name><name><surname>Young</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>LaVinka</surname><given-names>PC</given-names></name><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Bergles</surname><given-names>D</given-names></name><name><surname>Hanani</surname><given-names>M</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Spray</surname><given-names>DC</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Coupled activation of primary sensory neurons contributes to chronic pain</article-title><source>Neuron</source><volume>91</volume><fpage>1085</fpage><lpage>1096</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.07.044</pub-id><pub-id pub-id-type="pmid">27568517</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinboshi</surname><given-names>M</given-names></name><name><surname>Mukai</surname><given-names>T</given-names></name><name><surname>Nagao</surname><given-names>Y</given-names></name><name><surname>Matsuba</surname><given-names>Y</given-names></name><name><surname>Tsuji</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>S</given-names></name><name><surname>Tokudome</surname><given-names>K</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Ito</surname><given-names>H</given-names></name><name><surname>Ikeda</surname><given-names>A</given-names></name><name><surname>Inanobe</surname><given-names>A</given-names></name><name><surname>Kurachi</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>S</given-names></name><name><surname>Ohno</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Inhibition of inwardly rectifying potassium (kir) 4.1 channels facilitates brain-derived neurotrophic factor (BDNF) expression in astrocytes</article-title><source>Frontiers in Molecular Neuroscience</source><volume>10</volume><elocation-id>408</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2017.00408</pub-id><pub-id pub-id-type="pmid">29358904</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kofuji</surname><given-names>P</given-names></name><name><surname>Newman</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Potassium buffering in the central nervous system</article-title><source>Neuroscience</source><volume>129</volume><fpage>1045</fpage><lpage>1056</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2004.06.008</pub-id><pub-id pub-id-type="pmid">15561419</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koike</surname><given-names>T</given-names></name><name><surname>Kioke</surname><given-names>T</given-names></name><name><surname>Wakabayashi</surname><given-names>T</given-names></name><name><surname>Mori</surname><given-names>T</given-names></name><name><surname>Takamori</surname><given-names>Y</given-names></name><name><surname>Hirahara</surname><given-names>Y</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Sox2 in the adult rat sensory nervous system</article-title><source>Histochemistry and Cell Biology</source><volume>141</volume><fpage>301</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1007/s00418-013-1158-x</pub-id><pub-id pub-id-type="pmid">24170317</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostrzewa</surname><given-names>RM</given-names></name><name><surname>Jacobowitz</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>Pharmacological actions of 6-hydroxydopamine</article-title><source>Pharmacological Reviews</source><volume>26</volume><fpage>199</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">4376244</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuffler</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="1967">1967</year><article-title>Neuroglial cells: physiological properties and a potassium mediated effect of neuronal activity on the glial membrane potential</article-title><source>Proceedings of the Royal Society of London. Series B, Biological Sciences</source><volume>168</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1098/rspb.1967.0047</pub-id><pub-id pub-id-type="pmid">4382871</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurtz</surname><given-names>A</given-names></name><name><surname>Zimmer</surname><given-names>A</given-names></name><name><surname>Schnütgen</surname><given-names>F</given-names></name><name><surname>Brüning</surname><given-names>G</given-names></name><name><surname>Spener</surname><given-names>F</given-names></name><name><surname>Müller</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development</article-title><source>Development</source><volume>120</volume><fpage>2637</fpage><lpage>2649</lpage><pub-id pub-id-type="doi">10.1242/dev.120.9.2637</pub-id><pub-id pub-id-type="pmid">7956838</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>CH</given-names></name><name><surname>Luikart</surname><given-names>BW</given-names></name><name><surname>Powell</surname><given-names>CM</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Matheny</surname><given-names>SA</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Baker</surname><given-names>SJ</given-names></name><name><surname>Parada</surname><given-names>LF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Pten regulates neuronal arborization and social interaction in mice</article-title><source>Neuron</source><volume>50</volume><fpage>377</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2006.03.023</pub-id><pub-id pub-id-type="pmid">16675393</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledda</surname><given-names>M</given-names></name><name><surname>De Palo</surname><given-names>S</given-names></name><name><surname>Pannese</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Ratios between number of neuroglial cells and number and volume of nerve cells in the spinal ganglia of two species of reptiles and three species of mammals</article-title><source>Tissue &amp; Cell</source><volume>36</volume><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.tice.2003.09.001</pub-id><pub-id pub-id-type="pmid">14729453</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahfoud</surname><given-names>F</given-names></name><name><surname>Schlaich</surname><given-names>M</given-names></name><name><surname>Kindermann</surname><given-names>I</given-names></name><name><surname>Ukena</surname><given-names>C</given-names></name><name><surname>Cremers</surname><given-names>B</given-names></name><name><surname>Brandt</surname><given-names>MC</given-names></name><name><surname>Hoppe</surname><given-names>UC</given-names></name><name><surname>Vonend</surname><given-names>O</given-names></name><name><surname>Rump</surname><given-names>LC</given-names></name><name><surname>Sobotka</surname><given-names>PA</given-names></name><name><surname>Krum</surname><given-names>H</given-names></name><name><surname>Esler</surname><given-names>M</given-names></name><name><surname>Böhm</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study</article-title><source>Circulation</source><volume>123</volume><fpage>1940</fpage><lpage>1946</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.991869</pub-id><pub-id pub-id-type="pmid">21518978</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malpas</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Sympathetic nervous system overactivity and its role in the development of cardiovascular disease</article-title><source>Physiological Reviews</source><volume>90</volume><fpage>513</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1152/physrev.00007.2009</pub-id><pub-id pub-id-type="pmid">20393193</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancia</surname><given-names>G</given-names></name><name><surname>Bousquet</surname><given-names>P</given-names></name><name><surname>Elghozi</surname><given-names>JL</given-names></name><name><surname>Esler</surname><given-names>M</given-names></name><name><surname>Grassi</surname><given-names>G</given-names></name><name><surname>Julius</surname><given-names>S</given-names></name><name><surname>Reid</surname><given-names>J</given-names></name><name><surname>Van Zwieten</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The sympathetic nervous system and the metabolic syndrome</article-title><source>Journal of Hypertension</source><volume>25</volume><fpage>909</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1097/HJH.0b013e328048d004</pub-id><pub-id pub-id-type="pmid">17414649</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Mapps</surname><given-names>AA</given-names></name><name><surname>Thomsen</surname><given-names>MB</given-names></name><name><surname>Boehm</surname><given-names>E</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Hattar</surname><given-names>S</given-names></name><name><surname>Kuruvilla</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Diversity of Satellite Glia in Sympathetic and Sensory Ganglia</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2021.05.25.445647</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mapps</surname><given-names>AA</given-names></name><name><surname>Thomsen</surname><given-names>MB</given-names></name><name><surname>Boehm</surname><given-names>E</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Hattar</surname><given-names>S</given-names></name><name><surname>Kuruvilla</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Diversity of satellite glia in sympathetic and sensory ganglia</article-title><source>Cell Reports</source><volume>38</volume><elocation-id>110328</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.110328</pub-id><pub-id pub-id-type="pmid">35108545</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruoka</surname><given-names>H</given-names></name><name><surname>Kubota</surname><given-names>K</given-names></name><name><surname>Kurokawa</surname><given-names>R</given-names></name><name><surname>Tsuruno</surname><given-names>S</given-names></name><name><surname>Hosoya</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Periodic organization of a major subtype of pyramidal neurons in neocortical layer V</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>18522</fpage><lpage>18542</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3117-11.2011</pub-id><pub-id pub-id-type="pmid">22171052</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumata</surname><given-names>M</given-names></name><name><surname>Sakayori</surname><given-names>N</given-names></name><name><surname>Maekawa</surname><given-names>M</given-names></name><name><surname>Owada</surname><given-names>Y</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Osumi</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The effects of fabp7 and fabp5 on postnatal hippocampal neurogenesis in the mouse</article-title><source>Stem Cells</source><volume>30</volume><fpage>1532</fpage><lpage>1543</lpage><pub-id pub-id-type="doi">10.1002/stem.1124</pub-id><pub-id pub-id-type="pmid">22581784</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCaman</surname><given-names>MW</given-names></name><name><surname>McAfee</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Effects of synaptic activity on the metabolism and release of purines in the rat superior cervical ganglion</article-title><source>Cellular and Molecular Neurobiology</source><volume>6</volume><fpage>349</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1007/BF00711405</pub-id><pub-id pub-id-type="pmid">3829101</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDougal</surname><given-names>DH</given-names></name><name><surname>Gamlin</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Autonomic control of the eye</article-title><source>Comprehensive Physiology</source><volume>5</volume><fpage>439</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1002/cphy.c140014</pub-id><pub-id pub-id-type="pmid">25589275</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyuhas</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Physiological roles of ribosomal protein S6: one of its kind</article-title><source>International Review of Cell and Molecular Biology</source><volume>268</volume><fpage>1</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/S1937-6448(08)00801-0</pub-id><pub-id pub-id-type="pmid">18703402</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohr</surname><given-names>KM</given-names></name><name><surname>Pallesen</surname><given-names>LT</given-names></name><name><surname>Richner</surname><given-names>M</given-names></name><name><surname>Vaegter</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Discrepancy in the usage of GFAP as a marker of satellite glial cell reactivity</article-title><source>Biomedicines</source><volume>9</volume><elocation-id>1022</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines9081022</pub-id><pub-id pub-id-type="pmid">34440226</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muzumdar</surname><given-names>MD</given-names></name><name><surname>Tasic</surname><given-names>B</given-names></name><name><surname>Miyamichi</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A global double-fluorescent cre reporter mouse</article-title><source>Genesis</source><volume>45</volume><fpage>593</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1002/dvg.20335</pub-id><pub-id pub-id-type="pmid">17868096</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nacimiento</surname><given-names>W</given-names></name><name><surname>Schoen</surname><given-names>SW</given-names></name><name><surname>Nacimiento</surname><given-names>AC</given-names></name><name><surname>Kreutzberg</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Cytochemistry of 5′-nucleotidase in the superior cervical ganglion of cat and guinea pig</article-title><source>Brain Research</source><volume>567</volume><fpage>283</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(91)90807-8</pub-id><pub-id pub-id-type="pmid">1817732</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohara</surname><given-names>PT</given-names></name><name><surname>Vit</surname><given-names>JP</given-names></name><name><surname>Bhargava</surname><given-names>A</given-names></name><name><surname>Jasmin</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Evidence for a role of connexin 43 in trigeminal pain using RNA interference in vivo</article-title><source>Journal of Neurophysiology</source><volume>100</volume><fpage>3064</fpage><lpage>3073</lpage><pub-id pub-id-type="doi">10.1152/jn.90722.2008</pub-id><pub-id pub-id-type="pmid">18715894</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohno</surname><given-names>Y</given-names></name><name><surname>Kinboshi</surname><given-names>M</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inwardly rectifying potassium channel kir4.1 as a novel modulator of BDNF expression in astrocytes</article-title><source>International Journal of Molecular Sciences</source><volume>19</volume><elocation-id>3313</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19113313</pub-id><pub-id pub-id-type="pmid">30356026</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>ML</given-names></name><name><surname>Khakh</surname><given-names>BS</given-names></name><name><surname>Skatchkov</surname><given-names>SN</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>CJ</given-names></name><name><surname>Rouach</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>New insights on astrocyte ion channels: critical for homeostasis and neuron-glia signaling</article-title><source>Journal of Neuroscience</source><volume>35</volume><fpage>13827</fpage><lpage>13835</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2603-15.2015</pub-id><pub-id pub-id-type="pmid">26468182</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Pannese</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>The satellite cells of the sensory ganglia</article-title><conf-name>Advances in Anatomy, Embryology, and Cell Biology</conf-name></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renier</surname><given-names>N</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Simon</surname><given-names>DJ</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Ariel</surname><given-names>P</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>IDISCO: a simple, rapid method to immunolabel large tissue samples for volume imaging</article-title><source>Cell</source><volume>159</volume><fpage>896</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.10.010</pub-id><pub-id pub-id-type="pmid">25417164</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxton</surname><given-names>RA</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MTOR signaling in growth, metabolism, and disease</article-title><source>Cell</source><volume>168</volume><fpage>960</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.02.004</pub-id><pub-id pub-id-type="pmid">28283069</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlaich</surname><given-names>MP</given-names></name><name><surname>Lambert</surname><given-names>E</given-names></name><name><surname>Kaye</surname><given-names>DM</given-names></name><name><surname>Krozowski</surname><given-names>Z</given-names></name><name><surname>Campbell</surname><given-names>DJ</given-names></name><name><surname>Lambert</surname><given-names>G</given-names></name><name><surname>Hastings</surname><given-names>J</given-names></name><name><surname>Aggarwal</surname><given-names>A</given-names></name><name><surname>Esler</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation</article-title><source>Hypertension</source><volume>43</volume><fpage>169</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000103160.35395.9E</pub-id><pub-id pub-id-type="pmid">14610101</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiner</surname><given-names>B</given-names></name><name><surname>Romanelli</surname><given-names>E</given-names></name><name><surname>Liberski</surname><given-names>P</given-names></name><name><surname>Ingold-Heppner</surname><given-names>B</given-names></name><name><surname>Sobottka-Brillout</surname><given-names>B</given-names></name><name><surname>Hartwig</surname><given-names>T</given-names></name><name><surname>Chandrasekar</surname><given-names>V</given-names></name><name><surname>Johannssen</surname><given-names>H</given-names></name><name><surname>Zeilhofer</surname><given-names>HU</given-names></name><name><surname>Aguzzi</surname><given-names>A</given-names></name><name><surname>Heppner</surname><given-names>F</given-names></name><name><surname>Kerschensteiner</surname><given-names>M</given-names></name><name><surname>Becher</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Astrocyte depletion impairs redox homeostasis and triggers neuronal loss in the adult CNS</article-title><source>Cell Reports</source><volume>12</volume><fpage>1377</fpage><lpage>1384</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.07.051</pub-id><pub-id pub-id-type="pmid">26299968</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cardiac sympathetic denervation to prevent life-threatening arrhythmias</article-title><source>Nature Reviews. Cardiology</source><volume>11</volume><fpage>346</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2014.19</pub-id><pub-id pub-id-type="pmid">24614115</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott-Solomon</surname><given-names>E</given-names></name><name><surname>Kuruvilla</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Prenylation of axonally translated rac1 controls NGF-dependent axon growth</article-title><source>Developmental Cell</source><volume>53</volume><fpage>691</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2020.05.020</pub-id><pub-id pub-id-type="pmid">32533921</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>M</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>The regulation and function of c-fos and other immediate early genes in the nervous system</article-title><source>Neuron</source><volume>4</volume><fpage>477</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(90)90106-p</pub-id><pub-id pub-id-type="pmid">1969743</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ståhlberg</surname><given-names>M</given-names></name><name><surname>Nakagawa</surname><given-names>R</given-names></name><name><surname>Bedja</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>G</given-names></name><name><surname>Lin</surname><given-names>BL</given-names></name><name><surname>Saberi</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>DI</given-names></name><name><surname>Kass</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Chronic atrial and ventricular pacing in the mouse</article-title><source>Circulation. Heart Failure</source><volume>12</volume><elocation-id>e005655</elocation-id><pub-id pub-id-type="doi">10.1161/CIRCHEARTFAILURE.118.005655</pub-id><pub-id pub-id-type="pmid">30764638</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Schmidt</surname><given-names>TM</given-names></name><name><surname>Perez-Leighton</surname><given-names>CE</given-names></name><name><surname>Kofuji</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Inwardly rectifying potassium channel kir4.1 is responsible for the native inward potassium conductance of satellite glial cells in sensory ganglia</article-title><source>Neuroscience</source><volume>166</volume><fpage>397</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.01.005</pub-id><pub-id pub-id-type="pmid">20074622</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thireau</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>BL</given-names></name><name><surname>Poisson</surname><given-names>D</given-names></name><name><surname>Babuty</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Heart rate variability in mice: a theoretical and practical guide</article-title><source>Experimental Physiology</source><volume>93</volume><fpage>83</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1113/expphysiol.2007.040733</pub-id><pub-id pub-id-type="pmid">17911354</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tropea</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>MI</given-names></name><name><surname>Higgins</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Glial cells promote dendritic development in rat sympathetic neurons in vitro</article-title><source>Glia</source><volume>1</volume><fpage>380</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1002/glia.440010605</pub-id><pub-id pub-id-type="pmid">2976398</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsui-Pierchala</surname><given-names>BA</given-names></name><name><surname>Ginty</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Characterization of an NGF-P-trka retrograde-signaling complex and age-dependent regulation of trka phosphorylation in sympathetic neurons</article-title><source>The Journal of Neuroscience</source><volume>19</volume><fpage>8207</fpage><lpage>8218</lpage><pub-id pub-id-type="pmid">10493722</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Diepen</surname><given-names>MT</given-names></name><name><surname>Parsons</surname><given-names>M</given-names></name><name><surname>Downes</surname><given-names>CP</given-names></name><name><surname>Leslie</surname><given-names>NR</given-names></name><name><surname>Hindges</surname><given-names>R</given-names></name><name><surname>Eickholt</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>MyosinV controls PTEN function and neuronal cell size</article-title><source>Nature Cell Biology</source><volume>11</volume><fpage>1191</fpage><lpage>1196</lpage><pub-id pub-id-type="doi">10.1038/ncb1961</pub-id><pub-id pub-id-type="pmid">19767745</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vit</surname><given-names>JP</given-names></name><name><surname>Jasmin</surname><given-names>L</given-names></name><name><surname>Bhargava</surname><given-names>A</given-names></name><name><surname>Ohara</surname><given-names>PT</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Satellite glial cells in the trigeminal ganglion as a determinant of orofacial neuropathic pain</article-title><source>Neuron Glia Biology</source><volume>2</volume><fpage>247</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1017/s1740925x07000427</pub-id><pub-id pub-id-type="pmid">18568096</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vit</surname><given-names>JP</given-names></name><name><surname>Ohara</surname><given-names>PT</given-names></name><name><surname>Bhargava</surname><given-names>A</given-names></name><name><surname>Kelley</surname><given-names>K</given-names></name><name><surname>Jasmin</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Silencing the kir4.1 potassium channel subunit in satellite glial cells of the rat trigeminal ganglion results in pain-like behavior in the absence of nerve injury</article-title><source>The Journal of Neuroscience</source><volume>28</volume><fpage>4161</fpage><lpage>4171</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5053-07.2008</pub-id><pub-id pub-id-type="pmid">18417695</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vizi</surname><given-names>ES</given-names></name><name><surname>Liang</surname><given-names>SD</given-names></name><name><surname>Sperlágh</surname><given-names>B</given-names></name><name><surname>Kittel</surname><given-names>A</given-names></name><name><surname>Jurányi</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Studies on the release and extracellular metabolism of endogenous ATP in rat superior cervical ganglion: support for neurotransmitter role of ATP</article-title><source>Neuroscience</source><volume>79</volume><fpage>893</fpage><lpage>903</lpage><pub-id pub-id-type="doi">10.1016/s0306-4522(96)00658-6</pub-id><pub-id pub-id-type="pmid">9219952</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>AX</given-names></name><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>McCarthy</surname><given-names>KD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ganglionic GFAP+ glial gq-GPCR signaling enhances heart functions in vivo</article-title><source>JCI Insight</source><volume>2</volume><elocation-id>e90565</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.90565</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>S</given-names></name><name><surname>Younger</surname><given-names>SH</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Thompson-Peer</surname><given-names>KL</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Jan</surname><given-names>LY</given-names></name><name><surname>Jan</surname><given-names>YN</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Glial ensheathment of the somatodendritic compartment regulates sensory neuron structure and activity</article-title><source>PNAS</source><volume>116</volume><fpage>5126</fpage><lpage>5134</lpage><pub-id pub-id-type="doi">10.1073/pnas.1814456116</pub-id><pub-id pub-id-type="pmid">30804200</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Blundell</surname><given-names>J</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name><name><surname>Kwon</surname><given-names>CH</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Sinton</surname><given-names>C</given-names></name><name><surname>Powell</surname><given-names>CM</given-names></name><name><surname>Parada</surname><given-names>LF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Pharmacological inhibition of mtorc1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific pten knock-out mice</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>1773</fpage><lpage>1783</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5685-08.2009</pub-id><pub-id pub-id-type="pmid">19211884</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74295.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chao</surname><given-names>Moses V</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/005dvqh91</institution-id><institution>New York University Langone Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2021.09.23.461591" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2021.09.23.461591"/></front-stub><body><p>This study covers the understudied topic of satellite glia and its impact on sympathetic neuron survival. An unexpected increase in neuronal activity was observed when satellite glia were deleted by mouse genetics. Novel roles of satellite glia in sympathetic physiology were uncovered by physiology assays. An extensive response to the reviewers, along with the addition of supporting data, was provided by the authors.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74295.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Chao</surname><given-names>Moses V</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/005dvqh91</institution-id><institution>New York University Langone Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Carter</surname><given-names>Bruce D</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dq2gs74</institution-id><institution>Vanderbilt University Medical School</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.09.23.461591">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.09.23.461591v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Satellite glia are essential modulators of sympathetic neuron survival, activity, and autonomic function&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Ma-Li Wong as the Senior Editor. In addition, the following individual involved in the review of your submission has agreed to reveal their identity: Bruce D Carter (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this letter to help you prepare a revised submission. There is general agreement that the subject of satellite glial cells (SCG) is of considerable interest. However, the cellular ablation experiments brought several inconsistencies and matters of interpretation, which involve the impact of SGC upon sympathetic function.</p><p>Essential revisions:</p><p>1) The two targeted ablations with brain lipid binding protein (Blbp) directing diphtheria toxin and deletion of Kir4.1 require additional support for the conclusion that satellite glia are directly involved in the cellular effects on sympathetic and autonomic function. Since opposite actions are detected, it is necessary to reconcile the impact of satellite glia-ablation mice. This concern also raises questions about the specificity and efficacy of targeted expression.</p><p>2) It should be determined whether Kir4.1 is present in other cell types. Also, whether Blbp is driving diphtheria toxin in different cells. The effects of the Kir4.1 deletion may be due to alternative explanations, besides altered K buffering.</p><p>3) There is also a need to show that SGCs are depleted from sympathetic ganglia.</p><p>4) The results of the TUNEL assays require clarification and should be verified with glial and neuronal markers.</p><p>Extensive comments from the three reviewers are included below.<italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>There are numerous concerns regarding result interpretation. Therefore, the comments below address written text and figures.</p><p>Specific comments:</p><p>Title: &quot;Essential modulators&quot; is a subjective evaluation based on a single manipulation that may cause effects other than the removal of satellite glia. Suggested title: &quot;Satellite glial cells modulate sympathetic neuron survival, activity, and autonomic function.&quot;</p><p>l.28. The term &quot;how&quot; is ambiguous. Suggest replacing with &quot;the extent to which&quot; or &quot;whether,&quot; unless the intent is to determine the mechanism, which this study does not.</p><p>l.35 and l.81. Data do not so clearly support these statements. Yes, neuronal cellular deficits are recapitulated by Kir4.1 deletion in SGCs, but autonomic functional alterations are not, and the effects of Kir4.1 deletion are not proven to result from altered K buffering.</p><p>l.51. Satellite glia in parasympathetic and sensory ganglia have similar &quot;location and morphology&quot;; please clarify the distinction that is meant.</p><p>Figure 1 B. Staining in control for Blbp:iDTA appears more similar to p14 than p31 staining in panels in A. Moreover, in the Blbp:iDTA section, are SGCs less intense, thinner, or discontinuous around neurons? Scale bars in B,C, and upper panel in E are stated as 100 um. In comparison, cell diameters are clearly larger in E. Please verify calibrations. TUNEL labeling in C does not seem representative of quantification in D (minimal apparent labeling in control, vast amount in DTX); suggest black and white image without DAPI. Is there a difference in DAPI+ cells?</p><p>l.135. The data show that DTX deletion results in NE enzyme depletion; whether that reflects a necessity for SGCs to maintain the enzymes or DTX triggers their decline is not examined here.</p><p>L141. Soma areas should be compared using geometric means (median values) because data distribution is non-Gaussian.</p><p>l.145 and l.238. The use of pS6 to define mTOR activity is not very conclusive; others use it to measure neuronal activity, for example.</p><p>l. 172. Eye diameters differ in Figure 3A; please replace them with comparable images and add a scale bar.</p><p>l.199. The cFOS labeling and quantification appear at odds with each other. Staining in F seems to show many cells (even more than in Kir4.1 illustration Figure 4E), yet a mean 100 is shown in G. There are about 12000 neurons/ganglion (Figure 2F) so that fewer than 1% should be positive. Please illustrate with representative images.</p><p>l.218. There is concern that Kir4.1 appears to be present in some neurons in Figure 4A (upper left quadrant); please check this.</p><p>l.221. What is meant by SGC &quot;overall morphology&quot;? Overall, Blbp staining and complexity of SGCs seem less in the cKO in Figure S4B.</p><p>l.229. Was TH staining normal in axons of cKO mice?</p><p>l.230. Please change &quot;indicate&quot; for a such as &quot;suggest&quot; or a phrase such as &quot;are consistent with.&quot;</p><p>l.236. Please provide median soma areas.</p><p>l. 281. Spatial buffering should be considered in more detail, as indicated in public comments.</p><p>l.319. The opposite conclusions reached in a previous study using a different approach should be discussed in more detail.</p><p>l.329. Trophic effects previously reported for Kir4.1 include BDNF production and glutamate buffering; please expand the discussion to indicate roles of Kir4.1 in addition to K buffering.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>– Essential has a specific genetic meaning (i.e., when an essential-for-a-process gene is lacking, the process does not occur). The use of &quot;essential&quot; throughout the manuscript, including the title, to refer to SGCs' role is therefore not formally correct and may be misleading to the reader.</p><p>– The authors quantify <italic>Sox2</italic>(+) cells not associated with neuronal cell bodies, but since <italic>Sox2</italic> is a nuclear marker, how can the authors be sure that the cytoplasm associated with the quantified <italic>Sox2</italic>(+) nuclei are not in contact with neuronal cell bodies?</p><p>– The link between mTOR and SGC ablation is somewhat disjointed. Can the authors clarify in the text what the mechanistic link they envision is?</p><p>– In all figure legends, it would be helpful for the reader to indicate the time-point being examined. The absence of this information made it difficult to interpret the data mentioned above in Figure 1E vs. 2A, for example.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>Previous studies have indicated that satellite glia around sensory neurons in the DRG are also important for phagocytosing apoptotic neurons during development (Wu et al., 2009, PMC2834222). It would be interesting to know if satellite glia have a similar phagocytic role in the sympathetic ganglia, even in adult mice. Did the authors observe any of the apoptotic cells being engulfed by glia vs. macrophages? This is not necessary to address in this manuscript; I was just curious.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.74295.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The two targeted ablations with brain lipid binding protein (Blbp) directing diphtheria toxin and deletion of Kir4.1 require additional support for the conclusion that satellite glia are directly involved in the cellular effects on sympathetic and autonomic function. Since opposite actions are detected, it is necessary to reconcile the impact of satellite glia-ablation mice. This concern also raises questions about the specificity and efficacy of targeted expression.</p></disp-quote><p>We have performed additional experiments and analyses to demonstrate the specificity of BLBP and Kir4.1 expression in satellite glial cells. We also include new results that strengthen our conclusions that deficits in sympathetic neurons are responsible for autonomic dysfunction in satellite glia-ablated mice (BLBP:iDTA mice).</p><p>(i) We analyzed the expression of BLBP and Kir4.1 in peripheral ganglia using data-sets from our recently published single-cell RNA sequencing analysis of sympathetic and sensory ganglia from adult mice (postnatal days 30-45) (Mapps et. al, <italic>Cell Rep</italic> 2022). We show that BLBP (<italic>Fabp7</italic>) and Kir4.1 (<italic>Kcnj10</italic>) are highly enriched in satellite glial cells compared to other ganglionic cell types (∼140-fold enrichment for <italic>Fabp7</italic> and ∼3-fold for <italic>Kcnj10</italic>, respectively). These additional analyses are included in Figure 1—figure supplement 1A and Figure 4—figure supplement 1A, revised manuscript.</p><p>(ii) To further ensure the cellular specificity of BLBP, we generated genetic reporter mice by crossing <italic>Fabp7-CreER2</italic> mice with <italic>ROSA26<sup>mEGFP</sup></italic> mice, which drives expression of membrane-tagged EGFP. We observed m-EGFP reporter expression in satellite glia, but not in neurons, macrophages, or vascular mural cells in sympathetic ganglia, as revealed by co-immunolabeling studies. These new results are included in Figure 1—figure supplement 1C-F in the revised manuscript.</p><p>Together, these results indicate that BLBP and Kir4.1 are satellite glia-specific molecular markers. Our results are consistent with published data from other groups using single cell-sequencing of satellite glia (Avraham <italic>et al.</italic>, 2020; 2021; 2022), analyses of <italic>Fabp7-CreER2</italic> reporter mice (Avraham <italic>et al.</italic>, 2020), and Kir4.1 immunolabeling in peripheral ganglia (Vit <italic>et al.</italic>, 2006; 2008).</p><p>(iii) Reviewer #1 asked if the autonomic dysfunction observed in satellite glia-ablated mice (BLBP:iDTA mice) could be attributed to involvement of other cell types, for example, due to perturbed sensory or parasympathetic activity. In the original submission, we provided evidence that light-induced pupil constriction, a readout of parasympathetic function, is normal in BLBP:iDTA mice. To further strengthen the involvement of sympathetic neurons in the behavioral defects observed in BLBP:iDTA mice, we ablated sympathetic nerves using 6-OHDA, which selectively destroys sympathetic, but not parasympathetic or sensory nerves (Kostrzewa and Jacobowitz, 1974; Borden <italic>et al.</italic>, 2013). Further, 6-OHDA does not cross the blood-brain barrier after intraperitoneal injections in adult animals (Kostrzewa and Jacobowitz, 1974), restricting its actions to the periphery.</p><p>We include new data to show that ablation of sympathetic nerves prevents the elevation in heart rate in BLBP:iDTA mice (Figures 3E-F, revised manuscript). These results support the conclusion that the elevated heart rate in BLBP:iDTA mice specifically arises from defects in peripheral sympathetic neurons.</p><p>(iv) We respectfully disagree with the comment that “<italic>opposite actions are detected</italic>” in BLBP:iDTA and Kir4.1 cKO mice. Loss of Kir4.1 in satellite glia recapitulates all cellular phenotypes observed in BLBP:iDTA sympathetic neurons, specifically, increased neuronal activity, diminished mTOR signaling, soma atrophy, down-regulated expression of noradrenergic enzymes, and neuronal apoptosis. However, deletion of a single gene, Kir4.1, from satellite glia is not sufficient to drive behavioral changes at the whole animal level, as accomplished by genetic ablation of satellite glial cells. A reasonable explanation is that there are other satellite glia mechanisms, in addition to Kir4.1 activity, that contribute to regulation of neuronal excitability to drive circuit-level changes. We have discussed these additional mechanisms, for example, regulation of ATP signaling, in the Discussion (pages 16-17, revised manuscript).</p><disp-quote content-type="editor-comment"><p>2) It should be determined whether Kir4.1 is present in other cell types. Also, whether Blbp is driving diphtheria toxin in different cells.</p></disp-quote><p>See response above to point #1 regarding additional experiments and analyses that we performed to address cellular specificity of Kir4.1 and BLBP in satellite glia.</p><p>We also note that murine cells are naturally resistant to the uptake of diphtheria toxin (DT) because they lack receptors that bind to diphtheria toxin-subunit B (DTB), which is needed for the cellular entry of diphtheria subunit A (DTA) that has the catalytic activity for inhibition of protein synthesis in cells (Naglich et al., 1992). The <italic>ROSA26<sup>eGFP-DTA</sup></italic> mice has been used in several studies in combination with specific Cre-driver lines, and to our knowledge, there are few reports of non-cell-autonomous ablation. Thus, we conclude that in BLBP:iDTA mice, DTA expression is restricted to BLBP-positive satellite glial cells.</p><disp-quote content-type="editor-comment"><p>The effects of the Kir4.1 deletion may be due to alternative explanations, besides altered K buffering.</p></disp-quote><p>Reviewer #1 asks an interesting question of whether the sympathetic neuron phenotypes observed in Kir4.1 cKO mice could be due to mechanisms other than the reported function of Kir4.1 in spatial K<sup>+</sup> buffering. The Reviewer also suggests that peripheral satellite glia may not play a predominant role in K<sup>+</sup> buffering as their astrocytic counterparts in the CNS. We note that electrophysiological analyses show that satellite glial cells have high K<sup>+</sup> conductance, which is almost exclusively dependent on Kir4.1 expression (Tang <italic>et al.</italic>, 2010). Satellite glia are coupled to one another through gap junctions (Huang <italic>et al.</italic>, 2005; Kim <italic>et al.</italic>, 2016). RNAi-mediated knockdown of Kir4.1 or Connexin 43, a gap junction protein, enhances excitability of sensory neurons and evokes nociceptive responses in rats (Ohara <italic>et al.</italic>, 2008; Vit <italic>et al.</italic>, 2008). In this study, we find that satellite glia-specific Kir4.1 deletion result in increased sympathetic neuron activity, as revealed by enhanced c-Fos expression.</p><p>Together, these results suggest that satellite glial cells are capable of influencing neuronal excitability by dissipating extracellular K<sup>+</sup> increases via flow through a syncytium of coupled glial cells with high K<sup>+</sup> conductance, similar to astrocytes in the CNS (Tang <italic>et al.</italic>, 2010).</p><p>However, we agree with the Reviewer that we cannot exclude additional functions of Kir4.1. We have toned down the emphasis on spatial K<sup>+</sup> buffering as the primary mechanism by which Kir4.1 affects sympathetic neuron excitability and have expanded the Discussion (pages 15-16, revised manuscript) to discuss additional mechanisms, for example, the contribution of Kir4.1 to the hyperpolarized resting membrane potential of satellite glial cells (Tang et. al, 2010). Satellite glia membrane depolarization due to the loss of Kir4.1 could likely influence voltage-dependent processes in these cells. It has also been reported that loss of Kir4.1 enhances astrocytic BDNF release (Kinboshi <italic>et al.</italic>, 2017; Ohno <italic>et al.</italic>, 2018), which could then influence neuronal activity by regulating presynaptic mechanisms (Ameroso <italic>et al.,</italic> 2022). Thus, an analogous Kir4.1-BDNF pathway might operate in satellite glia to influence neuron activity, since BDNF is known to increase pre-synaptic input to post-ganglionic sympathetic neurons in sympathetic ganglia (Causing et al., 1997).</p><disp-quote content-type="editor-comment"><p>3) There is also a need to show that SGCs are depleted from sympathetic ganglia.</p></disp-quote><p>We include new data to show the ablation of satellite glial cells in BLBP:iDTA sympathetic ganglia.</p><p>(i) We performed co-labeling for TUNEL and Sox10, a satellite glia marker, to show enhanced apoptosis of satellite glial cells at 5 days post-tamoxifen injection in BLBP:iDTA sympathetic ganglia (Figures 1E, G, revised manuscript).</p><p>(ii) By q-PCR analyses, we show that levels of several satellite glia-specific transcripts, including <italic>Fabp7</italic> and <italic>Apoe</italic>, are significantly reduced in BLBP:iDTA sympathetic ganglia (Figure 1—figure supplement 2H, revised manuscript).</p><p>(iii) We directly addressed Reviewer #2’s comment that “the sox2<sup>+</sup> satellite glial cells do not appear to be gone 14 days post-tamoxifen injection, just dimmer” in Figure 1E of the original submission. We generated binary images of the Sox2-labeled cells by filtering and thresholding using Image J (details are provided in the Methods, page 40, revised manuscript). This method allows us to simply record the presence or absence of cells in the images in a manner independent of pixel values. Quantification of binary images revealed a significant decrease in the number of Sox2-labeled cells (33% decrease) in BLBP:iDTA ganglia at 14 days post-tamoxifen injections compared to controls (Figure 1—figure supplement 2D-G, revised manuscript). The 33% decrease in satellite glial cells is lower than the 54% loss we had initially reported, suggesting that we may have initially included some proportion of cells that had down-regulated Sox2 expression, but had not been ablated. We have clarified this point in the Results (page 7, revised manuscript).</p><p>As an additional measure to visualize sympathetic neurons and associated satellite glial cells in a manner that does not rely on fluorescence, we labeled sympathetic neurons using Tyrosine Hydroxylase (TH) DAB (3,3'-diaminobenzidine) immunohistochemistry, and identified the glial nuclei surrounding TH-positive sympathetic neurons by their distinctive appearance and location using Hematoxylin staining. Of note, despite several attempts, we were not successful in using <italic>Sox2</italic> or Sox10 antibodies in DAB immunohistochemistry. TH DAB immunohistochemistry and Hematoxylin labeling revealed a significant loss of glial nuclei associated with the soma of individual sympathetic neurons in BLBP:iDTA mice compared to control mice, at 14 days post-tamoxifen injection (Figures 1K-L, revised manuscript).</p><p>Together, with our data in the original submission, these new results demonstrate that we are indeed successfully ablating satellite glial cells in BLBP:iDTA mice, although the ablation is not complete.</p><disp-quote content-type="editor-comment"><p>4) The results of the TUNEL assays require clarification and should be verified with glial and neuronal markers.</p></disp-quote><p>We performed TUNEL labeling together with immunostaining for TrkA, a sympathetic neuron marker, and Sox10, a satellite glial cell marker, in BLBP:iDTA mice and control litter-mates at 5 days post-tamoxifen injection. We show that the majority of apoptotic cells at this stage are satellite glial cells; we quantified a 2-fold increase in glial apoptosis in BLBP:iDTA sympathetic ganglia at 5 days post-tamoxifen injection. Although, there was a trend toward enhanced neuronal apoptosis at this early stage, the number of TUNEL<sup>+</sup> sympathetic neurons in BLBP:iDTA ganglia was not statistically different from that in controls. These new results, included in Figures 1E-H, revised manuscript, suggest that satellite glia apoptosis precedes neuronal apoptosis in BLBP:iDTA sympathetic ganglia</p><p>Similar co-labeling analyses conducted in Kir4.1 cKO and control mice 14 days post-tamoxifen injections indicate that satellite glia-specific Kir4.1deletion elicits neuronal, but not, glial apoptosis, consistent with what we initially reported in the original submission. These new results are included in Figure 5—figure supplement 1B-E, revised manuscript.</p><disp-quote content-type="editor-comment"><p>Extensive comments from the three reviewers are included below.</p><p>Reviewer #1 (Recommendations for the authors):</p><p>There are numerous concerns regarding result interpretation. Therefore, the comments below address written text and figures.</p><p>Specific comments:</p><p>Title: &quot;Essential modulators&quot; is a subjective evaluation based on a single manipulation that may cause effects other than the removal of satellite glia. Suggested title: &quot;Satellite glial cells modulate sympathetic neuron survival, activity, and autonomic function.&quot;</p></disp-quote><p>We have changed the title as suggested by the Reviewer.</p><disp-quote content-type="editor-comment"><p>l.28. The term &quot;how&quot; is ambiguous. Suggest replacing with &quot;the extent to which&quot; or &quot;whether,&quot; unless the intent is to determine the mechanism, which this study does not.</p></disp-quote><p>As suggested, we have modified this sentence to “.., the extent to which sympathetic functions are influenced by satellite glia in vivo remains unclear”</p><disp-quote content-type="editor-comment"><p>l.35 and l.81. Data do not so clearly support these statements. Yes, neuronal cellular deficits are recapitulated by Kir4.1 deletion in SGCs, but autonomic functional alterations are not, and the effects of Kir4.1 deletion are not proven to result from altered K buffering.</p></disp-quote><p>We have modified the sentences to remove the emphasis on K<sup>+</sup> buffering.</p><disp-quote content-type="editor-comment"><p>l.51. Satellite glia in parasympathetic and sensory ganglia have similar &quot;location and morphology&quot;; please clarify the distinction that is meant.</p></disp-quote><p>We have modified this sentence to “Satellite glia have been largely characterized by their distinctive location and morphology in peripheral ganglia”.</p><disp-quote content-type="editor-comment"><p>Figure 1 B. Staining in control for Blbp:iDTA appears more similar to p14 than p31 staining in panels in A.</p></disp-quote><p>We find that the pattern of thin satellite glial covers enveloping neurons in P31 day-old wild-type mice in Figure 1A is consistent with the overall satellite glia morphology observed in control animals of similar age in Figure 1B. We also note that the magnification is different between the two images.</p><disp-quote content-type="editor-comment"><p>Moreover, in the Blbp:iDTA section, are SGCs less intense, thinner, or discontinuous around neurons?</p></disp-quote><p>Yes, this is consistent with satellite glia depletion in BLBP:iDTA sympathetic ganglia.</p><disp-quote content-type="editor-comment"><p>Scale bars in B,C, and upper panel in E are stated as 100 um. In comparison, cell diameters are clearly larger in E. Please verify calibrations.</p></disp-quote><p>We thank the Reviewer for pointing this out. We have corrected the scale bars for these images.</p><disp-quote content-type="editor-comment"><p>TUNEL labeling in C does not seem representative of quantification in D (minimal apparent labeling in control, vast amount in DTX); suggest black and white image without DAPI. Is there a difference in DAPI+ cells?</p></disp-quote><p>The graph in Figure 1D represents the total number of TUNEL-positive cells in the entire superior cervical ganglia (approximately 24-32 tissue sections of 12 μm thickness each), while images in Figure 1C show a single tissue section from the ganglia. We have inverted the images for better visualization as suggested.</p><p>There are no significant differences in the total number of sympathetic neurons between BLBP:iDTA and control ganglia at 5 days post-tamoxifen injections, when the TUNEL labeling was performed. These new results are provided in Figure 2—figure supplement 1B in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>l.135. The data show that DTX deletion results in NE enzyme depletion; whether that reflects a necessity for SGCs to maintain the enzymes or DTX triggers their decline is not examined here.</p></disp-quote><p>As noted above, DTA is only expressed in BLBP-positive satellite glial cells. Hence, we conclude that decreased expression of Norepinephrine (NE) biosynthetic enzymes in sympathetic neurons is an indirect effect of satellite glia loss.</p><disp-quote content-type="editor-comment"><p>L141. Soma areas should be compared using geometric means (median values) because data distribution is non-Gaussian.</p></disp-quote><p>Done. The new analyses are shown for BLBP:iDTA and Kir4.1 cKO mice in Figures 2D and 5B, respectively, in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>l.145 and l.238. The use of pS6 to define mTOR activity is not very conclusive; others use it to measure neuronal activity, for example.</p></disp-quote><p>Phospho-S6 (p-S6) is commonly used as a readout of mTOR activity (Meyuhas et. al, 2008). In the revised manuscript, we show that phosphorylation of another well-established downstream effector of mTOR activity, phospho-4E-BP1 (p-4E-BP1) (Saxton and Sabatini, 2017), is also reduced in BLBP:iDTA sympathetic neurons (Figure 2—figure supplement 1A) and Kir4.1 cKO sympathetic neurons (Figure 5—figure supplement 1A). Together, these results strengthen our initial conclusions that mTOR activity is reduced in sympathetic neurons with satellite glia ablation or satellite glia-specific Kir4.1 deletion.</p><p>Although p-S6 is also used as a readout for neuronal activity (Knight et al., 2012), this may not be the case for all neuronal populations. We observed enhanced sympathetic neuron activity in BLBP:iDTA and Kir4.1 cKO mice, based on enhanced c-Fos expression although these neurons had reduced p-S6 immunoreactivity.</p><disp-quote content-type="editor-comment"><p>l. 172. Eye diameters differ in Figure 3A; please replace them with comparable images and add a scale bar.</p></disp-quote><p>The eye diameters are different because BLBP:iDTA mice have increased sympathetic tone, resulting in larger pupil areas. We have added a scale bar to the images.</p><disp-quote content-type="editor-comment"><p>l.199. The cFOS labeling and quantification appear at odds with each other. Staining in F seems to show many cells (even more than in Kir4.1 illustration Figure 4E), yet a mean 100 is shown in G. There are about 12000 neurons/ganglion (Figure 2F) so that fewer than 1% should be positive. Please illustrate with representative images.</p></disp-quote><p>We re-analyzed the c-Fos data and have presented them as the percentage of TH-positive sympathetic neurons that are c-Fos-positive in the revised manuscript. We show that 21% of sympathetic neurons are c-Fos positive in BLBP:iDTA ganglia compared to 2.5% in controls (Figure 3I, revised manuscript). Similarly, 28% of sympathetic neurons are c-Fos-positive in Kir4.1 cKO ganglia compared to 2.4% in control ganglia (Figure 4F, revised manuscript).</p><disp-quote content-type="editor-comment"><p>l.218. There is concern that Kir4.1 appears to be present in some neurons in Figure 4A (upper left quadrant); please check this.</p></disp-quote><p>Kir4.1 (<italic>Kcnj10</italic> mRNA) is barely detected in sympathetic neurons based on single-cell RNA sequencing and immunostaining analyses (Figure 4—figure supplement 1A and Figure 1—figure supplement 1C). We replaced the original image in Figure 4A, revised manuscript.</p><disp-quote content-type="editor-comment"><p>l.221. What is meant by SGC &quot;overall morphology&quot;? Overall, Blbp staining and complexity of SGCs seem less in the cKO in Figure S4B.</p></disp-quote><p>We performed qPCR analysis to show that BLBP expression is unaffected in Kir4.1 cKO ganglia (Figure 4—figure supplement 1E)<bold>.</bold> We have also replaced the original image with one that shows that satellite glia morphology is comparable between Kir4.1 cKO and control sympathetic ganglia, based on BLBP immunostaining, (Figure 4—figure supplement 1F).</p><disp-quote content-type="editor-comment"><p>l.229. Was TH staining normal in axons of cKO mice?</p></disp-quote><p>TH staining in Kir4.1 cKO axons appears to be similar to that in control mice. We have included TH immunostaining and quantification of innervation density in new supplemental data (Figure 5—figure supplement 1F-G, revised manuscript).</p><disp-quote content-type="editor-comment"><p>l.230. Please change &quot;indicate&quot; for a such as &quot;suggest&quot; or a phrase such as &quot;are consistent with.&quot;</p></disp-quote><p>Done</p><disp-quote content-type="editor-comment"><p>l.236. Please provide median soma areas.</p></disp-quote><p>Done</p><disp-quote content-type="editor-comment"><p>l. 281. Spatial buffering should be considered in more detail, as indicated in public comments.</p></disp-quote><p>See detailed response to this point above in “Essential Revisions” and Reviewer 1’s “Public Review”.</p><disp-quote content-type="editor-comment"><p>l.319. The opposite conclusions reached in a previous study using a different approach should be discussed in more detail.</p></disp-quote><p>See detailed response above to the comments regarding the Xie <italic>et al.</italic>, study.</p><disp-quote content-type="editor-comment"><p>l.329. Trophic effects previously reported for Kir4.1 include BDNF production and glutamate buffering; please expand the discussion to indicate roles of Kir4.1 in addition to K buffering.</p></disp-quote><p>See detailed response to this point above in “Essential Revisions” and Reviewer #1’s “Public Review”.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>– Essential has a specific genetic meaning (i.e., when an essential-for-a-process gene is lacking, the process does not occur). The use of &quot;essential&quot; throughout the manuscript, including the title, to refer to SGCs' role is therefore not formally correct and may be misleading to the reader.</p></disp-quote><p>This has been corrected in the Title and elsewhere in the text as suggested.</p><disp-quote content-type="editor-comment"><p>– The authors quantify Sox2(+) cells not associated with neuronal cell bodies, but since Sox2 is a nuclear marker, how can the authors be sure that the cytoplasm associated with the quantified Sox2(+) nuclei are not in contact with neuronal cell bodies?</p></disp-quote><p>The Reviewer raises a good point. We cannot completely conclude whether satellite glial cells attach or not to neuronal soma based on labeling for <italic>Sox2</italic>, a nuclear marker. However, under normal conditions, given the close contacts between satellite glial cells and neuronal soma, with ultra-structural studies showing a 20 nm separation between neuronal and glial membranes (Pannese, 1981), satellite glia nuclei tend to have a characteristic arrangement often in a ring-like pattern around cell bodies of individual neurons. We only quantified <italic>sox2</italic><sup>+</sup> nuclei that were found in such an arrangement, immediately juxtaposed to neuronal soma that were delineated by TH immunolabeling.</p><disp-quote content-type="editor-comment"><p>– The link between mTOR and SGC ablation is somewhat disjointed. Can the authors clarify in the text what the mechanistic link they envision is?</p></disp-quote><p>Struck by the pronounced soma atrophy in sympathetic neurons from BLBP:iDTA and Kir4.1 cKO mice, we assessed mTOR signaling given its known role in regulating soma size and neuronal metabolism (Kwon et al., 2006; van Diepen et al., 2009; Zhou et al., 2009). We found a marked decrease in expression of p-S6, a key downstream effector of mTOR, using immunostaining. Notably, other groups have also reported that astrocyte-specific loss of Kir4.1 compromises mTOR signaling in spinal cord motor neurons leading to soma atrophy (Kelly et. al, 2018). In our study, to further support reduced neuronal mTOR signaling after satellite glia ablation or satellite glia-specific loss of Kir4.1, we include new results that show significant decrease in p-4-EBP1, another well-established readout of mTOR activity in BLBP:iDTA and Kir4.1 cKO sympathetic neurons (Figure 2—figure supplement 1A and Figure 5—figure supplement 1A).</p><p>These results suggest that glial cells (satellite glial cells and astrocytes) provide trophic support to neurons and promote soma growth, in part, via regulating mTOR signaling in neurons. We have clarified this point in the revised text (page 9).</p><disp-quote content-type="editor-comment"><p>– In all figure legends, it would be helpful for the reader to indicate the time-point being examined. The absence of this information made it difficult to interpret the data mentioned above in Figure 1E vs. 2A, for example.</p></disp-quote><p>Done.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>Previous studies have indicated that satellite glia around sensory neurons in the DRG are also important for phagocytosing apoptotic neurons during development (Wu et al., 2009, PMC2834222). It would be interesting to know if satellite glia have a similar phagocytic role in the sympathetic ganglia, even in adult mice. Did the authors observe any of the apoptotic cells being engulfed by glia vs. macrophages? This is not necessary to address in this manuscript; I was just curious.</p></disp-quote><p>This is an excellent point. As noted above to a similar point by Reviewer #2, it remains unknown whether satellite or macrophages or both are involved in clearing apoptotic debris in sympathetic ganglia. Although addressing this question is beyond the scope of this study, we plan to examine the phagocytic properties of satellite glia in future studies through sparse genetic labeling and confocal imaging and/or by electron microscopy.</p></body></sub-article></article>